Register!

Here are some of our extraordinary C3 Summit past speakers:

  • Image

    Wael Fakharany

    Regional Director,
    Egypt & North Africa
    Google

  • Image

    Chemi Peres

    Managing General Partner and Co-Founder,
    Pitango Venture Capital

  • Image

    John M. Dionisio

    Chairman
    Chief Executive Officer,
    AECOM

  • Image

    Aida Araissi

    Founder and Chief Executive Officer,
    Bilateral US-Arab Chamber of Commerce

  • Image

    Mr. Ron Bruder

    Founder & Chairman of the Board,
    Education for Employment (EFE)
    USA

  • Image

    Judith Barnett

    Founder & President,
    The Barnett Group, LLC

  • Image

    George Likourezos

    Partner,
    Carter, Deluca, Farrell & Schmidt LLP

  • Image

    Mr. Feniosky Peña-Mora

    Commissioner,
    New York City Department of Design
    & Construction

  • Image

    Matt Lauer

    Co-Anchor
    TODAY Show,
    NBC News

  • Image

    Dr. John Duke Anthony

    Founding President & CEO,,
    National Council on U.S.-Arab Relations,
    USA

  • Image

    Khalaf Ahmad Al Habtoor

    Chairman,
    Al Habtoor Group
    UAE

  • Image

    Mr. Danny E. Sebright

    President,,
    U.S.-U.A.E. Business Council,
    USA

  • Image

    Dr. Narendra Pai, MD

    Board Advisor,
    KMC
    USA

  • Image

    Mr. Andrew A. Baird

    CEO, Global,
    Education For Employment (EFE)
    USA

  • Image

    Todd P. Schwartz

    Deputy Special Representative,
    Commercial & Business Affairs
    U.S. Department Of State

  • Image

    Ken Close

    CEO & Founding Partner,
    The Quincy Group
    USA

  • Image

    Edward D. Burke, Jr.

    Edward Burke & Associates,
    Founder & Managing Partner

  • Image

    William Keppler

    Senior Associate, Board Advisor,
    C3 Summit, LLC

  • Image

    Laura Lombard

    President & Executive Director,
    Middle East & North Africa Consultants Association

  • Image

    Ken Dorph

    President & CEO,
    Sag Harbor Consulting

  • Image

    John L. Brooks III

    Managing Director,
    Healthcare Capital LLC
    USA

  • Image

    Mohamed Elkhashab

    CEO & President,
    Reach Media Inc.

  • Image

    Patrick N. Theros

    Former U.S. Ambassador, Qatar
    President and Executive Director
    U.S.-Qatar Business Council

  • Image

    Rahilla Zafar

    Author,
    Arab Women Rising

  • Image

    Chéma Gargouri

    CEO,
    Center for Applied Training
    Tunisia

  • Image

    Vishal Ahluwalia

    Thought Leader,
    Emerging Markets & Global Resourcing

  • Image

    Fuad M. Sahouri

    President and CEO,
    Sahouri Insurance and Financial

  • Image

    Randa Fahmy Hudome

    President,
    Fahmy Hudome International

  • Image

    Randa El-Sayed Haffar

    Director, Citi Private Bank
    Director,
    Elmer and Mamdouha Bobst Foundation

  • Image

    Walid G. Mansour

    Managing Partner,
    Middle East Venture Partners
    Beirut, Lebanon

  • Image

    Hala El Barkouky

    Founder & Managing Partner,
    Allied Business Consultants
    Cairo, Egypt

  • Image

    Robert Michael

    Chair
    Committee on MENA Affairs,
    New York City Bar Association

  • Image

    Hussain A. Qaragholi

    President of the US Business Council,
    Iraq

  • Image

    Laura Owen

    Founder & CEO,
    Ponsico

  • Image

    Dr. Andrew Scott Cooper

    Author,
    The Oil Kings

  • Image

    Karim Babay

    Founder
    Managing Partner
    Chief Investment Officer,
    Intrinsic Value Investment Partners

  • Image

    Hala Fadel

    Chair, MIT Enterprise Forum of Pan-Arab Region,
    Fund Manager, Comgest

  • Image

    Mona Aboelnaga Kanaan

    Managing Partner,
    K6 Investments LLC

  • Image

    Haifa Fahoum Al Kaylani

    Founder and Chairman,
    Arab International Women's Forum

  • Image

    Richard Hobson

    Vice President,
    Corporate Communications
    Olayan America

  • Image

    Mark Jaffe

    President & CEO,
    Greater New York Chamber of Commerce

  • Image

    Jessica Bruder

    Columbia University Graduate School of Journalism
    Journalist & Author,
    Burning Book: A Visual History of Burning Man

  • Image

    Michael R. Brew

    Partner,
    Carter, DeLuca, Farrell & Schmidt, LLP

  • Image

    Jason Scher

    Associate,
    Carter, Deluca, Farrell & Schmidt LLP

  • Image

    Eric A. Savage

    Shareholder,
    Littler Mendelson, PC

  • Image

    Rob Quartel

    CEO & Chairman,
    NTEL·X, Inc

  • Image

    H.E. Nassir Abdulaziz Al-Nasser

    Former Permanent Representative of Qatar to the United Nations
    Former Ambassador to Jordan,
    President of the Sixty-sixth Session of the UN General Assembly

  • Image

    Umar Farooq, Esq.

    Managing Partner,
    Farooq & Co LLC

  • Image

    Paul Sutphin

    Director,
    Middle East Partnership Initiative
    U.S. Department of State

  • Image

    Americo "Mack" Tadeu

    Deputy Director,
    Advocacy Center
    U.S. Department of Commerce

  • Image

    Dr. Aaron A. Salzberg

    Special Coordinator for Water Resources,
    Bureau of Oceans, Environment & Science
    U.S. Department of State

  • Image

    Richard W. Westerdale, II

    Director,
    Policy Analysis and Public Diplomacy
    Bureau of Energy Resources
    U.S. Department of State

  • Image

    Rula Shunnar

    Country Representative,
    Palestine & Jordan
    Silatech

  • Image

    Susan Peters

    Executive Director & COO,
    American Bankers Association of North America
    (ABANA)

  • Image

    Ambassador Stuart Beck

    United Nations Ambassador for Oceans and Seas,
    Republic of Palau

  • Image

    Fathi Saeed

    Managing Director,
    Natco Holding (a subsidiary of HSA Group)
    Chairman, Yemen Business Club
    Board Member and Employer Partner, EFE
    Yemen

  • Image

    Radwen Tekaya

    Senior Director,
    CARE EU Operations, Vistaprint
    Employer Partner, EFE-Tunisie
    Tunisia

  • Image

    Pamela P. Flaherty

    President & CEO,
    Citi Foundation
    Director, Corporate Citizenship
    Citi

  • Image

    Richard Wilson

    President,
    Saudi-US Trade Group
    SUSTG

  • Image

    Jean R. AbiNader

    Executive Director,
    Moroccan American Trade & Investment Center
    (MATIC)

  • Image

    Gayle Jennings-O’Byrne

    Vice President – Northeast (NY, NJ, CT),
    Workforce Readiness
    JPMorgan Chase Foundation

  • Image

    Emilio Williams-Lopez

    Executive Director,
    International Programs
    University of Chicago Medical Center

  • Image

    Amat Al Alim Alsoswa

    Managing Director
    Executive Bureau
    Acceleration of Aid Absorption and Support
    Policy Reforms

  • Image

    Ambassador Mohammed Al Hussaini Al Sharif

    Chief Representative to the United States,
    League of Arab States

  • Image

    Dr. David Paushter, M.D.

    Chairman, Department of Radiology,
    University of Chicago Medicine

  • Image

    Michael Brown

    Vice President Network Development,
    University of Chicago Medicine

  • Image

    Fareed Osman

    Chairman,
    Antigravity Group

  • Image

    Henri Asseily

    Partner,
    Leap Ventures
    Beirut, Lebanon

  • Image

    David S. Rose

    CEO,
    Gust

  • Image

    Lisa Anderson

    President,
    American University in Cairo

  • Image

    Christine Quigley

    Of Counsel,
    Catalano, Gallardo & Petropoulos

  • Image

    Katie Blot

    President,
    Blackboard

  • Image

    Lisa Balter Saacks

    VP,
    Gust

  • Image

    Peter Ford

    COO,
    Gulftainer
    UAE

  • Image

    Honourable Emma Hippolyte

    Minister for Commerce
    Business Development,
    Investment and Consumer Affairs
    Saint Lucia

  • Image

    Graham Macmillan

    Senior Program Manager
    For Financial Inclusion,
    Citi Foundation

  • Image

    Dr. Samar Alsaggaf

    Department of Medical and Health Science Programs,
    Saudi Arabian Cultural Mission

  • Image

    Dr. Husam H. Balkhy

    Associate Professor of Surgery
    Director,
    Minimally Invasive & Robotic Cardiac Surgery
    The University of Chicago Medicine

  • Image

    David Hoidal

    Partner,
    Medpoint Health Partners

  • Image

    HRH Prince Abdulaziz Bin Tala bin Abdulaziz Al Saud

    Member International Advisory Committee,
    National Council on U.S.-Arab Relations

  • Image

    Robert Starbuck

    CEO,
    Migrate Business Services

  • Image

    Talal M. Al Kaissi

    Chief of Staff & Advisor to the Commercial Counselor,
    UAE

  • Image

    Mohammed Barakat

    Managing Director,
    US-Qatar Business Council
    USA

  • Image

    Mohammed A. Ayoub

    Lead Design Principal,
    HDR Studio

  • Image

    Ehab Al Shihabi

    CEO,
    Al Jazeera America

  • Image

    Michael Sahouri

    Vice President,
    Sahouri Insurance & Financial

  • Image

    Dr. Mussaad Al-Razouki

    CEO,
    Kleos Healthcare Corporation
    Kuwait

  • Image

    Mohamed Malouche

    Chairman,
    Tunisian American Young Professionals

  • Image

    Amani Al-Khatahtbeh

    Media Relations Specialist,
    American-Arab Anti-Discrimination Committee

  • Image

    Wided Fakraoui

    Customer Representative,
    Vistaprint
    Tunisia
    Alumna
    Education for Employment (EFE)

  • Image

    Dr. Lawrence ("Larry") Friedman

    Associate Dean for Clinical Affairs;
    CEO
    UCSD International Professor of Pediatrics and Medicine,
    UC San Diego Health System

  • Image

    Ambassador Adam Ereli

    Former US Ambassador,
    Kingdom of Bahrain

  • Image

    Robert D. ("Bob") Hormats

    Vice Chairman,
    Kissinger Associates, Inc.

  • Image

    Christopher Painter

    Coordinator For Cyber Issues,
    U.S. Department of State

  • Image

    Dr. Fred Moavenzadeh

    Former President,
    Masdar Institute of Science and Technology

  • Image

    Maurice Sonnenberg

    Senior International Advisor,
    Guggenheim Securities, LLC

  • Image

    V. James Onalfo

    Former CIO & Deputy Commissioner,
    New York Police Department

  • Image

    Brendan Hannigan

    General Manager, Security Systems Division,
    IBM

  • Image

    Michael G. Dinning

    Director, Multimodal Programs and Partnerships,
    Volpe National Transportation Systems Center
    U.S. Department of Transportation

  • Image

    Dr. Rahmat Shoureshi

    Provost & Vice President,
    New York Institute of Technology

  • Image

    Dr. Sharri R. Clark

    Foreign Affairs Officer, Bureau of Counterterrorism,
    U.S. Department of State

  • Image

    Steve Fleischli

    Director & Senior Attorney, Water Program,
    Natural Resources Defense Council

  • Image

    Paul Houpt

    Controls Project Manager,
    General Electric Global Research

  • Image

    Dr. Tariq Samad

    Corporate Fellow
    and Global Innovation Leader,
    Honeywell Automation
    and Control Solutions

  • Image

    Michael Sonnenfeldt

    Founder & Chairman,
    Tiger 21

  • Image

    James Kaplan

    Partner,
    McKinsey & Company

  • Image

    Akhlesh Kaushiva

    Project Leader,
    Office of Electricity Delivery and Energy Reliability
    U.S. Department of Energy

  • Image

    Ana C. Rold

    Founder & Publisher,
    Diplomatic Courier

  • Image

    Dr. Massoud Amin

    Professor of Electrical & Computer Engineering
    Director of the Technological Leadership Institute,
    University of Minnesota

  • Image

    Andreas Sandre

    Press & Public Affairs Officer,
    Embassy of Italy, Washington, DC

  • Image

    Dr. Rae Zimmerman

    Professor of Planning and Public Administration,
    Wagner Graduate School of Public Service
    New York University

  • Image

    Kenneth D. Daly

    President,
    National Grid

  • Image

    Susan W. Brenner

    Samuel A. McCray Chair in Law,
    University of Dayton School of Law

  • Image

    Louis ("Lou") Zacharilla

    Co Founder
    Director of Development,
    Intelligent Community Forum

  • Image

    Khush Choksy

    Vice President for Turkey, Middle East, and North Africa Affairs,
    International Affairs
    U.S. Chamber of Commerce

  • Image

    Steve Curren

    Acting Chief
    Critical Infrastructure Protection Branch,
    U.S. Department of Health and Human Services

  • Image

    Elizabeth Richard

    Deputy Assistant Secretary of State,
    U.S. Department of State

  • Image

    Luke Ritter

    Executive Vice President,
    Ridge Global

  • Image

    Dr. Mark McGranaghan

    Vice President,
    Electric Power Research Institute

  • Image

    Dr. Efran Ibrahim

    Center Director,
    Cyber-Physical Systems Security & Resilience R&D
    National Renewable Energy Lab

  • Image

    Orville Schell

    Arthur Ross Director,
    Center on U.S.-China Relations
    Asia Society

  • Image

    Suneet Singh Tuli

    CEO,
    DataWind

  • Image

    Raj Pande

    Partner,
    Hutton & Williams

  • Image

    Peter Gish

    Partner,
    UPC, Renewables

  • Image

    Keith ("Spike") Gentile

    Director,
    Air Force & Special Programs Business Development
    L-3 Communications, Communications Systems West

  • Image

    Joseph M. Carriere

    Director, Strategic Pursuits;
    Acting Director, Ew/Cyber,
    L-3 Communications, Advanced Programs Division

  • Image

    Russ Quinn

    Director,
    Air Force Business Development
    L-3 Communications, Communications Systems East

  • Image

    Pat Holub

    Business Development Manager,
    US Navy Surface Ship Programs & Middle East Opportunities
    L-3 Communications, Communications Systems East

  • Image

    Robin Chase

    Co-Founder & Former CEO,
    Zipcar

  • Image

    Bryan Berthy

    Director, Mission Systems,
    Engineering & Technical Operations
    Lockheed Martin Aeronautics

  • Image

    Thomas A.W. Miller

    Diplomatic & Global Business Lead,
    Bloomberg BNA

  • Image

    John P. Desrocher

    Deputy Assistant Secretary of State for
    Egypt and Maghreb Affairs

  • Image

    William R. Gregory

    Director of Program Services,
    UltiSat

  • Image

    Dr. John P. Entelis

    Professor of Political Science,
    Chair of Political Science Department
    Director of the Middle East Studies Program
    Fordham University

  • Image

    Paul C. Homsy

    Partner,
    Eaton & Van Winkle

  • Image

    Tim Baker

    Director of Strategic Initiatives,
    MTA Bridges and Tunnels
    New York City

  • Image

    Muneer A. Baig

    Founder & CEO,
    SYSUSA Inc.

  • Image

    David Batsford

    Chairman and CEO,
    SmartPoints Technology

  • Image

    Prachi Vakharia

    Business Development,
    RideAmigos

  • Image

    Mysore Nagaraja

    Chairman & Co-Founder,
    Spartan Solutions, LLC

  • Image

    Dr. Bessma Momani

    Associate Professor,
    Balsillie School of International Affairs
    University of Waterloo:Ontario, Canada

  • Image

    Paul Doherty

    President & CEO,
    IFMA Fellow, DFC Senior Fellow,,
    TDG - the digit group, inc.,
    USA

  • Image

    M.G. ("Moe") Abutaleb

    CEO,
    UltiSat, Inc.

  • Image

    Mohammad Adil “Mak” Khan-Qasmi

    President,
    US Halal Association

  • Image

    Thomas A. Dukes, Jr.

    Deputy Coordinator for Cyber Issues,
    Office of the Secretary of State
    United States Department of State

  • Image

    Hampton Dowling

    Founder & Managing Partner,
    HCB Group LLC

  • Image

    John Oldfield

    CEO,
    Wash Advocates

  • Image

    Chuck Mitman

    Managing Partner,
    Rainmaker Worldwide, Inc

  • Image

    Jothy Rosenberg

    Associate Director,
    Cyber Systems Group
    Draper Laboratory

  • Image

    Seth M. Cannon

    Partner,
    Carter, DeLuca, Farrell & Schmidt, LLP

  • Image

    General Wesley K. Clark, (ret.)

    CEO,
    Wesley K. Clark & Associates, LLC

  • Image

    Mr. Steven J. Thompson, MBA

    Senior Vice President
    Chief Business Development Officer,
    Brigham and Women's Healthcare
    USA

  • Image

    Samer Khoury

    President of Engineering & Construction,
    Consolidated Contractors Company
    Greece

  • Image

    Kathleen Regan

    Executive Vice President
    Chief Operating Officer
    The Commonwealth Fund;
    Board of Trustees
    Boston Children’s Hospital;
    Board of Trustees,
    Boston Children’s Hospital

  • Image

    Ms. Mariam Farag

    Head of Corporate Social Responsibility,
    Middle East Broadcasting Center (MBC) Group
    UAE

  • Image

    Dr. Walid A. Fitaihi

    Founder
    Chairman of the Board of Directors
    Chief Executive Officer,
    International Medical Center (IMC)
    KSA

  • Image

    Dr. Ala Alwan

    World Health Organization
    Eastern Mediterranean Regional Director;
    Visiting Professor
    Department of Global Health,
    University of Washington
    USA

  • Image

    Ambassador Leslie Rowe

    Office of Global Health Diplomacy,
    U.S. Department of State

  • Image

    Dr. Brian Jacobs

    Vice President
    Chief Medical Information Officer
    Chief Information Officer,
    Children's National Health System
    USA

  • Image

    Dr. Adnan Hammad

    President & CEO,
    Global Health Research
    Management & Solutions
    USA

  • Image

    Honorable Suresh Kumar

    Independent Board Director
    Former US Assistant Secretary of Commerce,
    Member of Sanofi’s Executive Committee
    USA

  • Image

    Dr. Adam Landman

    Vice President and Chief Information Officer
    Brigham Health (BH)
    Attending Emergency Physician at BWH;
    Assistant Professor of Emergency Medicine ,
    Harvard Medical School
    USA

  • Image

    Florian Kemmerich

    Managing Partner
    Bamboo Capital Partners;
    Founder,
    Ryan-Kay
    Switzerland

  • Image

    Dr. Nihal (“Nina”) Afifi

    Global Health Policy and Management
    EPOS Health Management,
    Harvard
    T.H. Chan
    School of Public Health
    USA

  • Image

    Dr. Allen Kachalia

    Chief Quality Officer
    Brigham Health;
    Associate Professor of Medicine
    Harvard Medical School;
    Associate Professor of Health Policy & Management,
    Harvard School of Public Health
    USA

  • Image

    Dr. Karl Laskowski

    Associate Medical Director
    Brigham and Women’s Physicians
    Organization (BWPO);
    Instructor of Medicine,
    Harvard Medical School
    USA

  • Image

    Mr. Joseph DeVivo

    President,
    Hospital & Health Systems,,
    Teladoc Health, Inc.,
    USA

  • Image

    Mr. Rizwan ("Riz") Khan

    Author
    Former Senior Anchor,
    CNN International
    UAE

  • Image

    Reeta Roy

    President & CEO,
    Mastercard Foundation
    Canada

  • Image

    Mr. Philippe Krolicki

    Founder & CEO,
    p-valorem
    USA

  • Image

    Mr. Olivier Jarry

    CEO,
    Lifnano
    United Kingdom

  • Image

    Mr. Nawaf Althari

    Political Adviser
    Counter-Terrorism
    Counter-Piracy Focal Point
    OIC Focal Point,
    Kingdom of Saudi Arabia
    Permanent Mission to the United Nations
    USA

  • Image

    Stephen P. Nash

    Partner, Co-Leader,
    International Healthcare Practice Group
    Squire Patton Boggs
    USA

  • Image

    Dr. Gabi Hanna, MD

    CEO, Co-Founder,
    Lamassu Pharma, LLC;
    Executive Director,
    Duke Translational Research Center;
    Associate Director,
    Duke Cancer Institute, Surgical Facility;
    VP, American Remote Health, USA

  • Image

    Ambassador Mr. Marc Ginsberg

    Former US Ambassador,
    Morocco

  • Image

    Ambassador Isobel Coleman

    Chief Operating Officer
    GiveDirectly,
    former US Ambassador to the UN for:
    Management, Reform & Special Political Affairs
    USA

  • Image

    Jared Kushner


  • Image

    Ellen Lord

    President & Chief Executive Officer,
    Textron Systems

  • Image

    Dr. Henry Kissinger

    Chairman,
    Kissinger Associates, Inc.
    Former Secretary of State
    United States of America

  • Image

    General David H. Petraeus

    US Army, Retired;
    Former Director, Central Intelligence Agency;
    Chairman,
    KKR Global Institute

  • Image

    His Excellency Shaikh Khalid bin Ahmed Al Khalifa

    Minister of Foreign Affairs,
    Bahrain Foreign Minister

  • Image

    Rabbi Arthur Schneier

    Founder & President,
    Appeal of Conscience Foundation

  • Image

    Ambassador William Roebuck

    US Ambassador to Bahrain

  • Image

    Ambassador Joseph Westphal

    US Ambassador to Kingdom of Saudi Arabia

  • Image

    Dr. Evan P. Nadler

    Co-Director
    Children's National Obesity Institute;
    Director
    Adolescent Weight Loss Surgery Program,
    Children's National Health System
    USA

  • Image

    Tamara Cofman Wittes

    Senior Fellow - Foreign Policy,
    Center for Middle East Policy
    Brookings Institution
    USA

  • Image

    Ms. Jasmine Nahhas di Florio

    Senior Vice President
    Strategy & Partnerships,
    Education For Employment (EFE)
    USA

  • Image

    Dr. Raymond F. Schinazi

    Professor of Pediatrics
    Director of the Laboratory of Biochemical Pharmacology
    Emory University;
    Co-Director
    HIV Cure Scientific Working Group,
    NIH-sponsored Emory University CFAR
    USA

  • Image

    The Honorable Deborah L. Wince-Smith

    President & CEO,
    Council on Competitiveness
    USA

  • Image

    H.E. Dr. Adnan Al-Ansari

    Former Ambassador of Permanent Mission of GCC to the United Nations,
    Oman

  • Image

    H.H. Dr. Sayyida Basma Al Said

    Founder,
    Whispers of Serenity's
    Mental Health Counselor and Psychotherapist
    Oman

  • Image

    Talal Braidy

    Director of Global Business Development,
    Houston Methodist Global Health Care Services EMEA
    Kingdom of Saudi Arabia

  • Image

    Affan Khalfan Al Akhzami

    Managing Director & CEO,
    ICEM
    Oman

  • Image

    Annette Maresh

    Vice President
    Trade Finance and Insurance,
    U.S. Export/Import Bank
    USA

  • Image

    Hiba Zalatimo

    Education For Employment (EFE) Graduate;
    Manager,
    Hospitality Academy
    Caesar Hotel
    Palestine

  • Image

    H.E. Dr. Hilal Ali Al Sabti

    Executive President,
    Oman Medical Specialty Board;
    Senior Consultant Cardiothoracic Surgeon
    Sultan Qaboos University Hospital
    Oman

  • Image

    Ambassador Frances D. Cook

    Former Ambassador,
    Sultanate of Oman
    USA

  • Image

    Dr. Linda A. Lee

    Associate Professor of Gastroenterology and Hepatology
    The Johns Hopkins University School of Medicine, USA;
    Chief of Staff,
    Johns Hopkins Aramco Healthcare (JHAH)
    Kingdom of Saudi Arabia

  • Image

    Ms. Kate Karwelies

    Sales Vice President,
    Aetna International
    USA

  • Image

    Dr. Rabi Hanna

    Director of Pediatric of Blood and Marrow Transplantation,,
    Department of Pediatric Hematology and Oncology,
    Cleveland Clinic,
    USA

  • Image

    Dr. José Iglesias

    Medical Director of
    International Services and Pediatric Surgery;
    Secretary
    Cook Children’s Physician Network Board of Directors,
    Cook Children's Healthcare System
    USA

  • Image

    Ms. Cynthia Gonzalez

    Executive Director,
    International Patient Services Program,,
    Cook Children’s Health Care System,
    USA

  • Image

    Dr. Danny R. Thomas

    Founder & President,
    Water for the World
    USA

  • Image

    David A. Paterson

    55th Governor of New York State;
    Director/Investments,
    Stifel, Nicolaus & Company

  • Image

    Dr. Nizar N. Zein, MD

    Director,
    Hepatology Center;
    Chairman,
    Global Patient Services,,
    The Cleveland Clinic,
    USA

  • Image

    Dr. Yousef Al Weshahi

    Department Chair
    Examination, Certification, Continuing Professional Development,
    Oman Medical Specialty Board
    Oman

  • Image

    Tracey Webb

    Vice President
    Structured Finance and Insurance,
    Overseas Private Investment Corporation (OPIC)
    USA

  • Image

    Hala El-Mohandes

    Vice President
    Structured and Project Finance,
    U.S. Export/Import Bank
    USA

  • Image

    Mr. Ali Abdul Hussain Shaban

    Chief Corporate Affairs Officer,
    W J Towell Group LLC.
    Oman

  • Image

    Ms. Maimuna Said Al-Sulaimani

    General Counsel;
    Effective Board Member (EBM),
    PricewaterhouseCoopers (PwC-UK)
    Oman

  • Image

    Mr. Isaac Blech

    Founder & Director, Cerecor
    Founder of Celgene; ICOS (developer of Cialis);
    Nova Pharmaceutical; Pathogenesis;
    Genetics Systems Corporation;,
    USA

  • Image

    Mr. Andy Tucker

    Founder,
    Two Lions Holdings
    USA

  • Image

    Dr. Bavaguthu Raghuram ("B.R.") Shetty

    Founder and Chairman of NMC Healthcare
    Founder and Chairman of Finablr;
    Founder and Chairman of Neopharma;
    Founder and Chairman of BRS Ventures;
    UAE

  • Image

    Dr. Pamela Sherman, MD

    Medical Director
    International Patient Services and Director;
    Hand surgery Program,
    Cook Children's Medical Center
    USA

  • Image

    Mr. Stan Davis

    COO
    Senior Vice President,
    Cook Children's Health Care System
    USA

  • Image

    Ms. Cheryl Petersen

    CNO
    Senior Vice President,
    Cook Children's Medical Center
    USA

  • Image

    Ms. Jill Koss

    Director
    Family Support Services,
    Cook Children's Medical Center
    USA

  • Image

    Dr. Charles Pozner

    Associate Professor Emergency Medicine,
    Harvard Medical School;
    Brigham and Women's Hospital
    USA

  • Image

    Dr. Douglas S. Smink

    Associate Professor in Surgery
    Harvard Medical School;
    General Surgeon of Minimally Invasive Surgery,
    Brigham and Women's Hospital
    USA

  • Image

    Ms. Madelyn "Maddy" Pearson

    Senior Vice President
    Chief Nursing Officer
    Patient Care Services,
    Brigham and Women's Hospital
    USA

  • Image

    Dr. Daniele Rigamonti

    CEO,
    Johns Hopkins Aramco Healthcare
    Kingdom of Saudi Arabia

  • Image

    Mr. Angelo DiMaggio

    CEO/Founder,
    American BackPain Center
    American Headache Institute
    USA

  • Image

    Dr. Omneya A. Darwish

    Vice President for Global Outreach and Engagement,
    Smart Consult
    Egypt & USA

  • Image

    Mr. Bishoy M. Mikhail

    Associate Chairman
    Philanthropy Institute;,
    Cleveland Clinic Innovations
    USA

  • Image

    Ms. Zainab Salbi

    Founder: Women for Women International
    Author: Freedom Is an Inside Job ,
    TV Host
    Iraq/USA

  • Image

    Dr. Stella George, MBBS

    Head of Americas Care Management,
    Aetna International
    USA

  • Image

    Ms. Tuba Terekli

    Saudi Arabia High Commissioner
    of ,
    World Business Angels' Forum
    Kingdom of Saudi Arabia

  • Image

    Dr. Sameh El-Saharty

    Program Manager
    &
    Human Development
    GCC Countries & Mena Region,
    The World Bank
    Egypt

  • Image

    Dr. Ahmed Emara

    Group CEO and Managing Director,
    ReAya Holding
    Kingdom of Saudi Arabia

  • Image

    Dr. Herbert I. London

    President,
    London Center for Policy Research
    USA

  • Image

    Dr. Subroto Chatterjee

    Professor,
    Departments of Pediatrics-Cardiology
    Johns Hopkins University School of Medicine
    USA

  • Image

    Dr. John Lantis

    Vice Chairman
    Department of Surgery;
    Chief of Vascular and Endovascular Surgery,
    Mount Sinai
    USA

  • Image

    Dr. Aftab Ahmed

    Vice President & Chief Science Officer,
    PureLife Health Sciences Group
    USA

  • Image

    Dr. Khawla S. Al-Kuraya

    Professor of Pathology
    Director Research Centre
    KFNCCC,
    King Faisal Specialist Hospital & Research Centre
    Kingdom of Saudi Arabia

  • Image

    Mr. Duncan Darrow

    Founder & Chairman,
    The Cancer Trust
    USA

  • Image

    Dr. Ashraf El Fiky, MD PhD

    President
    Chief Scientist,
    Smart Consult
    USA and Egypt

  • Image

    Mr. Fady Yacoub

    Managing Partner,
    HOF Capital
    Egypt & USA

  • Image

    Ms. Paige Peterson

    Executive Vice President,
    Huntsman Cancer Foundation
    USA

  • Image

    Mr. Alan Gilbert

    Chief Growth Officer,
    V3 Health Strategy
    USA

  • Image

    Mr. Omar Darwazah

    General Partner,
    Arab Angel Fund
    USA

  • Image

    Dr. Asmus Hammerich

    Director
    Noncommunicable Diseases and Mental Health (NMH),
    World Health Organization
    Eastern Mediterranean Region
    Egypt

  • Image

    Dr. Rana Hajjeh

    Director
    Department of Communicable Diseases,
    Eastern Mediterranean Region;
    EMRO RD Candidate
    World Health Organization
    Egypt

  • Image

    Dr. Felicia Hill-Briggs

    Johns Hopkins School of Medicine;
    Bloomberg School of Public Health;
    Johns Hopkins School of Nursing;,
    Johns Hopkins HealthCare LLC
    USA

  • Image

    Ms. Katherine Malmay-Bazemore

    CEO,
    Cocoon Resources, Inc.
    USA

  • Image

    Ms. Miriam Oueslati Khiari

    President,
    Islamic Heritage, Inc.
    USA/Tunisia

  • Image

    Dr. Faisal Zagzoog

    Otolaryngology-Head and Neck ,
    King Abdulaziz University
    Kingdom of Saudi Arabia

  • Image

    Dr. Ahmed El-Saifi, MD

    Founder
    Al-Borg Diagnostic Laboratories;
    Professor Emeritus,
    Cairo University Faculty of Medicine
    Egypt

  • Image

    Nahlah Al-Jubier

    Director,
    Center for Career Development
    Saudi Arabian Cultural Mission

  • Image

    Ms. Ruma Bose

    Consultant,
    Consultant, Serial Entrepreneur, Investor,
    Philanthropist,
    Author,
    USA

  • Image

    Ms. Tala Al Jabri

    Non-executive Board Director at Ento Capital
    Fellow,
    Harvard University;
    Strategy & Finance Advisor
    USA/KSA

  • Image

    Dr. Sean T. Manion

    CEO,
    Science Distributed
    USA

  • Image

    Dr. Mohamed El Ammary, MD, PhD

    Head of Health Affairs Committee,
    Parliament
    Egypt

  • Image

    Mr. Mohammed Sohail Chaudhry

    Chief Technology Officer
    Director of Infrastructure Operations (Acting),
    United States Food and Drug Administration (FDA)
    USA

  • Image

    Mr. Muneer A. Baig

    Founder & CEO,
    SYSUSA Inc

  • Image

    Mr. Jared Elkins

    President & CEO,
    Alitheia Holdings
    USA

  • Image

    Dr. Roland Turck, MD

    Managing Director,
    TurckBio

  • Image

    H.E. Shaikh Abdulla Bin Rashid Al Khalifa

    Ambassador U.S. Embassy,
    Kingdom of Bahrain

  • Image

    Mr. Alexander Golding

    CEO,
    HelpedHope
    USA

  • Image

    Dr. Philip A. DeFina, PhD

    Founder, CEO, Chief Scientific Officer,
    International Brain Research Foundation
    USA

  • Image

    Dr. Charles J. Prestigiacomo

    Professor of Neurosurgery,
    Neurosurgeon

  • Image

    Dr. Amit Kumar

    CEO & President,
    Eminent Physicians LLC
    USA

  • Image

    Dr. Eugene Lipov

    Anesthesiology,
    Advanced Pain Centers, S.C.
    USA

  • Image

    Dr. James Halper

    Psychiatry,
    Lenox Hill Hospital
    USA

  • Image

    H.E. Ambassador Sandeep Chakravorty

    Consulate General of India,
    New York
    USA

  • Image

    H.E. Dr. Abdullatif bin Rashid Al Zayani

    Secretary-General,
    Cooperation Council for the Arab States of the Gulf (GCC)

  • Image

    Dr. Djaoued Bedjaoui, MD

    Senior Medical Advisor for Health,,
    Embassy of the United Arab Emirates,
    Washington, D.C.,
    USA

  • Image

    Ms. Cathy Easter

    President and CEO
    Houston Methodist,
    Global Health Care Services;
    Senior Vice President
    Community Development
    USA

  • Image

    Dr. Kurt Newman, MD

    President and CEO,
    Children's Hospital
    Washington, D.C.
    USA

  • Image

    Ms. Carmel Mulvany

    Advisor,
    United Nations
    Office for Partnerships
    USA

  • Image

    Ambassador Salah Sarhan

    Chief Representative,
    League of Arab States Mission
    Washington, DC
    USA

  • Image

    Ms. Oualae Alami

    Vice President
    Cluster Lead
    Egypt, Levant, Iraq and Iran
    Biopharmaceutical Group,
    Pfizer
    Dubai

  • Image

    Dr. James D. Marshall, MD

    Vice President
    Chief Research Officer,
    Pediatric Critical Care Medicine
    Cook Children's Health Care System
    USA

  • Image

    Princess Dina Mired of Jordan

    President,
    Union for International Cancer Control (UICC)
    Jordan

  • Image

    Ms. Doreen Bogdan-Martin

    Director,
    International Telecommunication Union
    Telecommunication Development Bureau (BDT)
    USA

  • Image

    Dr. Sawsan A. S. Al Madhi

    Director General,
    Friends of Cancer Patients
    UAE

  • Image

    President and CEO,
    Cook Children's Healthcare System
    USA

  • Image

    Mr. Saad Al-Badry

    Chairman & CEO,
    NEXGEN Biopharma
    Dubai, UAE

  • Image

    Mr. Hassan Damluji

    Author,
    United Kingdom

  • Image

    Ms. Swetha Somasundaram

    Vice President - Market Access
    General Medicines and Emerging Markets,
    Sanofi
    USA

  • Image

    Dr. James E. Shmerling, DHA, FACHE

    President and Chief Executive Officer,
    Connecticut Children's Medical Center
    USA

  • Image

    Mr. Han Shen Chia

    Humanitarian Director,
    GiveDirectly
    USA

  • Image

    Dr. Naqib Safi

    Senior Emergency Coordinator
    Emergency Response Team EMOPS,
    Unicef
    USA

  • Image

    Mr. David Schlotterbeck

    Chairman of the Board,
    Immunicom, Inc.
    USA

  • Image

    Mr. Amir Jafri

    CEO/Co-Founder,
    Immunicom, Inc.,
    USA

  • Image

    Vice Admiral Walter Davis

    Co-Founder, Vice President
    Organizational Development,
    EvoNexus
    USA

  • Image

    Mr. Shahid Shah

    CEO/Founder,
    Netspective Corporation
    USA

  • Image

    Mr. Sameer Jafri

    President/Co-Founder,
    Revive Solutions
    USA

  • Image

    Mr. Michael W. Brown, MHA

    President and Chief Executive Officer,
    MD Anderson Services Corporation;
    MD Anderson Physicians Network
    USA

  • Image

    Dr. Nureldin Satti

    Ambassador to the United States,,
    Sudanese Embassy,
    Washington, DC,
    USA,
    Sudan

  • Image

    Mr. Robert Steven Kramarz

    Founder & Executive Director,
    Intelliversity,
    USA

  • Image

    Dr. Sapna Syngal

    Director of GI Cancer Genetics and Prevention Program,,
    Dana-Farber Cancer Institute,
    USA

  • Image

    Dr. Claus Jensen, PhD

    Chief Innovation Officer,
    Teladoc Health,
    USA

  • Image

    Hon. Lawrence Silverman

    US Ambassador (ret),
    US Embassy,
    Kuwait,
    USA

  • Image

    President Bill Clinton

    Founder of the William J. Clinton Foundation,
    42nd President of the United States

  • Image

    Dr. Mohamad Alabdulaali

    Assistant Minister, Ministry of Health,
    Kingdom of Saudi Arabia

  • Image

    Mr. H. Delano Roosevelt

    Director
    New Business Development,
    Reza Investment Group,
    Kingdom of Bahrain

  • Image

    David T. Martin

    Associate Medical Director,
    International Patient Center;
    Vice Chair,
    Network Development & Innovative Care Solutions,,
    Brigham & Women's Hospital,
    USA

  • Image

    Dr. Rafael A. Irizarry

    Professor,,
    Biostatistics and Computational Biology,
    Dana-Farber Cancer Institute,
    USA

  • Image

    M.Sc. Polona Šafarič Tepeš

    Visiting Scientist,
    Cold Spring Harbor Laboratory,
    Researcher University Of Ljubljana,
    Director of Girls In Science for SDG,
    RASIT
    Ljubljana, Slovenia

  • Image

    Dr. Salam Al-Bader

    Founder & CEO,
    Albader Ventures Inc;
    Deputy Chairman,
    Global House of Bahrain,
    Kuwait

  • Image

    Mr. David Jackson

    Founder & Chairman,,
    Solitaire Partners,
    USA

  • Image

    HRH Prince Salman bin Hamad Al Khalifa

    Crown Prince,
    Deputy Supreme Commander
    and
    Prime Minister,
    Kingdom of Bahrain

  • Image

    His Excellency Shaikh Abdulla R. Al Khalifa

    The Ambassador of Kingdom of Bahrain to the United States

  • Image

    Dr. Jason Dictenberg

    CEO,
    AccelBio,
    USA

  • Image

    Mr. William B. Wittmeyer

    CEO, Founder,
    Pulmostics LTD,
    USA

  • Image

    Dr. T. Peter Kingham, MD, FACS

    Asst. Attending Surgeon,,
    Division of Hepatopancreatobillary,
    Memorial Sloan Kettering Cancer Center,
    USA

  • Image

    Dr. Michael McDermott, M.D.,

    Chief Medical Executive,,
    Miami Neuroscience Institute,
    Part of Baptist Health South Florida,
    USA





Speaker Bios 2022 (Subject to Change)

Princess Reema bint Bandar bin Sultan bin Abdulaziz Al Saud (Saudi Ambassador to the United States, Saudi Arabia)

Her Royal Highness Princess Reema Bandar Al Saud was appointed Ambassador to the United States on February 23, 2019, by the Custodian of the Two Holy Mosques King Salman bin Abdulaziz. She is the first woman in the country’s history to serve in the role of Ambassador. She presented her credentials to President Donald Trump on July 8, 2019.

In Saudi Arabia, Princess Reema focused on private sector initiatives and the empowerment of women in the Kingdom. From 2007 until 2015, Princess Reema was the Chief Executive Officer of Alfa International Company Limited - Harvey Nichols Riyadh, a multi-brand luxury retail company, during which she commissioned a study on Obstacles for Women in the Workplace, which set the tone for female inclusion in retail and resulted in opening the first workplace nursery. In 2013, she founded Alf Khair, a social enterprise aimed at elevating the professional capital of Saudi women through a curriculum developed to enable financial self-sufficiency.

In 2016, Princess Reema left the private sector to begin a career of public service as Vice President of Women’s Affairs at the Saudi General Sports Authority where she developed policies and programs that benefited women and children throughout Saudi Arabia. After a successful year, she was promoted to Deputy of Development and Planning in January 2018. In October 2018, she was also appointed President of the Mass Participation Federation, making her the first woman to lead a multi-sports federation in the Kingdom, a role that she occupied until her appointment as Saudi Ambassador to the United States.

As part of her philanthropic work, Princess Reema became a founding member of the Zahra Breast Cancer Awareness Association in 2007, which set a Guinness World Record by forming the World’s Largest Human Awareness Ribbon at Princess Noura University in Riyadh in 2015.

She received a Bachelor of Arts in Museum Studies from George Washington University and an honorary doctorate from Marymount University.

Princess Reema has served as a member of the World Bank’s advisory council for the Women Entrepreneurs Finance Initiative since 2017. She has been a member of the Saudi Arabian Olympic Committee since 2017-2019 and a member of the International Olympic Committee (IOC) Women in Sports Commission since 2018. She is also a member of the IOC Brisbane 2032 Coordination Commission.

Princess Reema also serves as the Chairman of the Executive Committee of the Fashion Commission at the Ministry of Culture, and as an Honorary Chairman of the Saudi Special Olympics. Princess Reema is a member of the Voting Council for the RBG Awards. She also serves as a Board Member for Panthera’s Conservation Council and the Future Investment Initiative.

Dr. Rahul Gupta MD, MPH, MBA, FACP (DIRECTOR OF NATIONAL DRUG CONTROL POLICY, White House, USA)

Dr. Rahul Gupta,MD, MPH, MBA, FACP is the first medical doctor to ever lead the White House Office of National Drug Control Policy (ONDCP). Dr. Gupta most recently served as the Chief Medical and Health Officer, Interim Chief Science Officer and Senior Vice President at March of Dimes. In his role, Dr. Gupta provided strategic oversight for March of Dimes’ domestic and global medical and public health efforts. He recently served as clinical Professor in the Department of Medicine at Georgetown University School of Medicine as well as adjunct professor in the Department of Health Policy, Management and Leadership in the School of Public Health at West Virginia University and visiting faculty at Harvard T.H. Chan School of Public Health.

A practicing primary care physician of 25 years, Dr. Gupta began his career in private practice in an underserved community of fewer than 2,000 residents. He has since served under two Governors as the Health Commissioner of West Virginia. As the state’s Chief Health Officer, he led the opioid crisis response efforts and launched a number of pioneering public health initiatives, including the Neonatal Abstinence Syndrome Birthscore program to identify high-risk infants. Dr. Gupta also led the development of the state’s Zika action plan and its preparedness efforts during the Ebola Virus Disease Outbreak.

Both a recognized national and global thought leader and a driver of innovative public policies on health issues, Dr. Gupta serves as an advisor to several organizations and task forces on local, national and international public health policy. The son of an Indian diplomat, Dr. Gupta was born in India and grew up in the suburbs of Washington, D.C. At age 21, he completed medical school at the University of Delhi. He earned a master’s degree in public health from the University of Alabama-Birmingham and a global master’s of business administration degree from the London School of Business and Finance. He is married to Dr. Seema Gupta, a physician in the Veterans Administration for over a decade. They are the proud parents of identical twin sons.

Dr. George Cheriyan, MD, FRCP, FRCPI, MBA (Corporate CEO/Chief Medical Officer, American Mission Hospital, Bahrain)
Dr. George Cheriyan, MD, FRCP (Lon), FRCPI, MBA is the Corporate CEO and Chief Medical Officer of the American Mission Hospital (AMH) in Bahrain, the oldest hospital in the GCC. He worked as a Neonatologist for over 25 years after obtaining his post graduate training in Pediatrics in London at The Hospital for Sick Children, Great Ormond Street, and sub-specialization in Neonatology at the Hospital for Sick Children, in Toronto, Canada.

Dr. Cheriyan has also worked as a Consultant Neonatologist in the National Health Service In London before moving up to take up a position as Head of Neonatology at the Saudi Aramco Hospital where he worked for 18 years in various capacities of leadership. He is a trained ‘Improvement Advisor’ in Healthcare quality from the Institute of Healthcare Improvement (IHI) in Boston, MA where he was adjunct teaching member of the faculty and has been an invited speaker at various healthcare Forums both in and outside of the US.

He further obtained training in Healthcare management at the Harvard Business School and is both an alumni of the Harvard Business School and the Harvard Kennedy School of Government. His area of interest is the economics in developing a model of non-profit healthcare which is both affordable and of high quality.
Prof. Eyal Zimlichman, MD, MSc (MHCM) (Chief Transformation Officer, Chief Innovation Officer, Sheba Medical Center, Israel; FOUNDER AND DIRECTOR, ARC, ISRAEL)

Prof. Eyal Zimlichman is an internal medicine physician, a health care executive and a researcher focused on assessing and improving health care quality and value, patient engagement and patient safety.

Prof. Zimlichman currently serves as Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center, Israel's largest hospital. In this position he oversees the transformation efforts carried out at the Medical Center as it aims to redesign healthcare to be focused on patients, while being more effective, efficient and equitable. For these reasons, Prof. Zimlichman founded Sheba’s global innovation program (ARC – Accelerate, Redesign and Collaborate). Prior to this Prof. Zimlichman held the position of Chief Medical Officer and before that as Chief Quality Officer, both at Sheba.

Preceding his work at Sheba, Prof. Zimlichman held the position of Lead Researcher at Partners Health Care Clinical Affairs Department in Boston where he was involved in the efforts to bring about a strategic care redesign initiative. In that capacity, Prof. Zimlichman established their program for collecting and reporting patient reported outcomes across the continuum of care, a program that earned international appraisal. During that time, Prof. Zimlichman held an appointment at Brigham and Women’s Hospital and Harvard Medical School affiliated Center for Patient Safety Research and Practice, where he conducted research on implementing technology to improve quality and patient safety.

Prof. Zimlichman is a founding member of the International Academy of Quality and Safety in Health Care and an International Expert at the International Society of Quality in Healthcare (ISQua). He also served as an advisor to the Office of the National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services.

In 2007 Prof. Zimlichman was selected as a member of Sheba's Talpiot Medical Leadership Program, a program aimed at advancing the brightest young physicians into leadership roles. In 2017 he was appointed head of the program. Prof. Zimlichman is a graduate of the Harvard School of Public Health Master of Science in Healthcare Management program and has earned his MD at the Technion Israel Institute of Technology.

Dr. Ghassan Abou-Alfa, MD, MBA (Attending Memorial Sloan Kettering Cancer Center, Professor at Weill Cornell College at Cornell University; Trustee of American University of Beirut; International Affairs Steering Committee, American Society of Clinical Oncology, USA)
Dr. Ghassan Abou-Alfa, MD, MBA joined the Gastrointestinal Oncology Service at Memorial Sloan Kettering Cancer Center in New York back in 2001. Dr. Abou-Alfa specializes in the treatment of gastrointestinal cancers and in particular, liver cancer. Dr. Abou-Alfa received his medical degree from the American University of Beirut, Lebanon, and completed his post-doctoral training at Yale University School of Medicine. He received his MBA from Columbia University.

Dr. Abou-Alfa serves as the chair of the National Cancer Institute (NCI) Task Force for Hepatobiliary Cancers, the chair of the AIDS Malignancy Consortium (AMC) Non-AIDS Defining Malignancies (NADC) Liver/GI Task Force, and is the President-Elect for the International Society of Gastrointestinal Oncology. Dr. Abou-Alfa has lectured worldwide on the subject on gastrointestinal malignancies. He serves as the chair the medical/scientific board of the Cholangiocarcinoma Foundation and the Blue Faery Liver Foundation, and also serves on the National Medical Advisory Committee of the American Liver Foundation.

Dr. Abou-Alfa has also spearheaded many international projects since 2006, and now serves on the institutional leadership panel for international healthcare. Dr. Abou-Alfa helped Memorial Sloan Kettering Cancer Center establish a strong relationship with many institutions worldwide, with an ongoing faculty exchange, repeated video-link conferencing, and class-training courses with China and the Middle East. These joint collaborations have led to the development of the first joint tissue bank with a shared database with Memorial Sloan-Kettering Cancer Center and supported fellowship opportunities for excelling medical graduates. Dr. Abou-Alfa has also helped promote and enhance the MSKCC international patients’ referral base.
Dr. Larry Norton, MD (Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast Center; Norna S. Sarofim Chair in Clinical Oncology, USA)

Dr. Larry Norton, MD is a board-certified medical oncologist with broad interests in cancer prevention, diagnosis, and treatment. In his clinical practice, he cares for women with breast cancer, and is Medical Director of the Evelyn H. Lauder Breast Center. His research concerns the basic biology of cancer; the mathematics of tumor causation and growth; and the development of approaches to better diagnosis, prevention, and drug treatment of the disease. He is involved in many areas of research including identifying the genes that predispose people to cancer or that cause cancer, developing new drugs, monoclonal antibodies that target growth factor receptors, and vaccines. A major milestone in his research career was the development of an approach to therapy called “dose density,” or “sequential dose density.” This is a new and more effective way of using anticancer drugs, based on a mathematical model he developed with his colleagues, which maximizes the killing of cancer cells while minimizing toxicity.

He is currently the principal investigator of a program project grant from the National Cancer Institute (NCI) that is aimed at better understanding breast cancer in the laboratory and in bringing these advances into clinical practice.

On a national level, Dr. Norton was formerly the Chair of the Breast Committee of the NCI’s Cancer and Leukemia Group B. He was also President of the American Society of Clinical Oncology (ASCO) from 2001 to 2002, and was appointed by President Clinton to serve on the National Cancer Advisory Board (the board of directors of the NCI).

Among many awards over the course of his career, he was honored to receive ASCO’s highest honor, the David A. Karnofsky Award, and was McGuire Lecturer at the San Antonio Breast Cancer Symposium. He is an author of more than 350 articles and many book chapters, has served as a visiting professor throughout the United States, Canada, South America, Europe, Israel, and Asia, and also has trained many cancer doctors and researchers.

My research concerns the basic biology of cancer; the mathematics of tumor causation and growth; and the development of approaches to better diagnosis, prevention, and drug treatment of the disease. I am involved in many areas of research including identifying the genes that predispose people to cancer or that cause cancer, developing new drugs, monoclonal antibodies that target growth factor receptors, and vaccines. A major milestone in my research career was the development of an approach to therapy called “dose density,” or “sequential dose density.” This is a new and more effective way of using anticancer drugs, based on a mathematical model I developed with my colleagues, which maximizes the killing of cancer cells while minimizing toxicity.

I am currently the principal investigator of a program project grant from the National Cancer Institute (NCI) that is aimed at better understanding breast cancer in the laboratory and in bringing these advances into clinical practice. On a national level, I was formerly the Chair of the Breast Committee of the NCI’s Cancer and Leukemia Group B. I was President of the American Society of Clinical Oncology (ASCO) from 2001 to 2002, and was appointed by President Clinton to serve on the National Cancer Advisory Board (the board of directors of the NCI).

Among many awards over the course of my career, I was honored to receive ASCO’s highest honor, the David A. Karnofsky Award, and was McGuire Lecturer at the San Antonio Breast Cancer Symposium. I am an author of more than 350 articles and many book chapters, have served as a visiting professor throughout the United States, Canada, South America, Europe, Israel, and Asia, and also have trained many cancer doctors and researchers.

Ambassador Dr. Deborah L. Birx (White House Coronavirus Task Force 2020-2021, USA)

Deborah L. Birx, MD is a world-renowned medical physician and expert on HIV/AIDS and infectious diseases and a diplomat who served as a special representative for global health diplomacy. Most recently, Dr. Birx served on the White House Coronavirus Task Force from Feb. 2020 to Jan. 2021. Her three-decade-long career has focused on HIV/AIDS immunology, vaccine research, and global health. As the U.S. Global AIDS Coordinator for presidents Barack Obama and Donald Trump, Dr. Birx oversaw the implementation of the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), the largest commitment by any nation to combat a single disease in history, as well as all U.S. government engagement with the Global Fund to Fight AIDS, Tuberculosis, and Malaria. Serving as the U.S. Special Representative for Global Health Diplomacy, she aligned the U.S. Government’s diplomacy with foreign assistance programs that address global health challenges and accelerate progress toward achieving an AIDS-free generation; ending preventable child and maternal deaths; and preventing, detecting, and responding to infectious disease threats.

In 1985, Dr. Birx began her career with the Department of Defense (DoD) as a military-trained clinician in immunology, focusing on HIV/AIDS vaccine research. From 1985-1989 she served as an Assistant Chief of the Hospital Immunology Service at Walter Reed Army Medical Center. Through her professionalism and leadership in the field, she served as the Director of the U.S. Military HIV Research Program (USMHRP) at the Walter Reed Army Institute of Research from 1996-2005. Dr. Birx helped lead one of the most influential HIV vaccine trials in history (known as RV 144, or the Thai trial), which provided the first supporting evidence of any vaccine’s potential effectiveness in preventing HIV infection. During this time, she also rose to the rank of Colonel, bringing together the Navy, Army, and Air Force in a new model of cooperation – increasing the efficiency and effectiveness of the U.S. military’s HIV/AIDS efforts through inter-and intra-agency collaboration. Then known as Colonel Dr. Birx, she was awarded two prestigious U.S. Meritorious Service Medals and the Legion of Merit Award for her groundbreaking research, leadership and management skills during her tenure at DoD.

From 2005-2014, Dr. Birx served as the Director of the Centers for Disease Control and Prevention's (CDC) Division of Global HIV/AIDS (DGHA) in the CDC Center for Global Health. As DGHA Director, she utilized her leadership ability, superior technical skills, and passion to achieve tremendous health impact. She successfully led the implementation of CDC’s PEPFAR programs around the world and managed an annual budget of more than $1.5 billion. Dr. Birx was responsible for all of the agency's global HIV/AIDS activities, including providing oversight to more than 400 staff at headquarters, over 1,500 staff in the field, and more than 45 country and regional offices in Africa, Asia, the Caribbean, and Latin America. Recognized for her distinguished and dedicated commitment to building local capacity and strengthening quality laboratory health services and systems in Africa, in 2011, Dr. Birx received a Lifetime Achievement Award from the African Society for Laboratory Medicine. In 2014, CDC honored her leadership in advancing the agency’s HIV/AIDS response with the highly prestigious William C. Watson, Jr. Medal of Excellence, the highest honor bestowed by the CDC.

Dr. Birx received her medical degree from the Hershey School of Medicine, Pennsylvania State University. She trained in internal medicine and basic and clinical immunology at the Walter Reed Army Medical Center and the National Institutes of Health. Dr. Birx is board certified in internal medicine, allergy and immunology, and diagnostic and clinical laboratory immunology. She has published over 220 manuscripts in peer-reviewed journals, authored nearly a dozen chapters in scientific publications, as well as developed and patented vaccines.

Dr. Maliha Hashmi (PROMINENT HEALTH LEADER, ONE OF TOP SEVEN FEMALE HEALTH LEADERS, MENA REGION, KINGDOM OF SAUDI ARABIA)

Dr. Maliha Hashmi is winner of the prestigious Forbes Health Leadership Award of 2022 and part of the World Leaders Award recipients. She is also one of the Top Seven Most Talented Female Health Leaders of the MENA region. She is well-known as one of the dedicated and esteemed leaders in the region who has committed herself to bringing positive change, wellness and growth to the Kingdom of Saudi Arabia. Dr. Maliha Hashmi served as the Executive Director and Co-Head of the Health, Wellbeing and Biotech Sector at NEOM, where she also served as the Executive Director for all Strategic Partnerships. Dr. Maliha Hashmi also served as the Deputy Chair of the NEOM Covid-19 Leadership Taskforce. She also has Senior Executive Advisory roles in various KSA entities where she advises on healthcare and education.

Dr. Maliha Hashmi serves as a Board Member of the prestigious Advisory Board for Arab Health: the largest multi-disciplinary congress in the MENA Region. Dr. Maliha Hashmi is also a Board Member of the Halal Certification Authority part of the Saudi Food Drug Authority. She is also an Advisory Board Member of social impact investing in the Kingdom. Dr. Hashmi also serves as a Leading Expert & Council Member for the Prestigious Global Future Council on Health & Healthcare at the World Economic Forum.

Furthermore, Dr. Maliha Hashmi serves as a Leading Expert & Council Member for the Global Future Council on Longevity at the World Economic Forum. Dr. Hashmi is a also a Leading Expert and Council Member for the Emerging Technologies Councils in the MENA Region which is part of the Big Innovation Center, an award winning global innovation technology think tank. Dr. Maliha Hashmi, is also an esteemed delegate of the V20, where V20 is a global platform of value experts and practitioners that has come together on the sidelines of the G20 presidency to actively engage with the process of the Group of Twenty (G20). She is also a regular contributor for Forbes. Dr. Maliha Hashmi has held Senior Executive roles in various sectors and globally renowned organizations and is a well-known name in the region for health & wellbeing. Dr. Maliha Hashmi received her Doctorate and Master’s Degrees from Harvard and MIT. Dr. Maliha Hashmi is listed as one of the top 20 women in the Nation in the United States of America for her achievements making it into the Who’s Who in America List.

Mr. Phillip Mervis (Chairman & CEO, BioSAFE Engineering, USA)

BioSAFE technology provides environmentally responsible solutions for the treatment and disposal of biologic and medical waste. The company also serves specialized high containment government and private laboratories, vaccine production facilities, and leading agricultural research centers, to eliminate the threat of hazardous or infectious agents.

Prior to leading BioSAFE Engineering, Mr. Mervis was COO of Mervis Industries, one of the largest private recyclers in the USA, recycling over 1 billion pounds per year of metals, plastics, paper, and electronics. Mr. Mervis has leveraged this experience to make BioSAFE a leader in solutions that enable recycling medical and laboratory plastics.

Dr. Minesh Mehta, MD (Deputy Director, Chief of Radiation Oncology, Miami Cancer Institute, Part of Baptist Health South Florida, USA)

Dr Minesh P. Mehta, M.D. is a world-renowned expert in radiation oncology, proton therapy and cancer research. He is Deputy Director and Chief of Radiation Oncology of Miami Cancer Institute at Baptist Health South Florida.

Dr. Mehta graduated from the University of Zambia School of Medicine and completed his residency at the University of Wisconsin, where he was chief resident in radiation oncology.

Prior to joining Baptist Health, Dr. Mehta served as Medical Director of the University of Maryland’s Proton Treatment Center, the first dedicated pencil-beam proton treatment center in the mid-Atlantic, which he launched. In addition, he was associate director of clinical research at the University of Maryland School of Medicine’s Department of Radiation Oncology.

Previously, he was the chairman of the University of Wisconsin School of Medicine and Public Health’s Department of Human Oncology, where he led numerous research studies, innovative technology innovation and implementation (Tomotherapy), and substantial practice expansion of the University of Wisconsin Cancer Center Clinical operations. He was also program leader for the University of Wisconsin’s Comprehensive Cancer Center’s Imaging and Radiation Sciences Program for under 15 years, led a program project grant in radiation oncology, and has been the chair of the RTOG/NRG oncology’s brain tumor committee for over 15 years.

Dr. Mehta has designed and led several national and international clinical studies, receiving NIH and NCI grants and been awarded many honors. He has held national leadership positions in numerous organizations including the American Board of Radiology, the FDA Radiological Devices Panel, the American Society for Radiation Oncology, the American Society of Clinical Oncology, the Society of Neuro-Oncology, etc.

Captain Suzanne Lesko ((Retired/US Navy), Federal Partner, Kyndryl, USA)

Suzanne is a proven tri-sector leader with over 25-plus years of outstanding experience in the defense and national security industries. As a combat veteran, Suzanne is part of an elite group of women to rise to the rank of Captain in the U.S. Navy, the 1% of the 1% club. Her passion is high-impact leadership and human performance, and she is a strong advocate for women, peace, and security. Suzanne is a native of Pittsburgh, Pennsylvania, and comes from a family of veterans, with her father serving in the U.S. Air Force and her sister serving in the U.S. Navy.

She began her Navy career as a U.S. Naval Aviator and has trained America’s elite combat teams to act optimally in high-pressure, complex, and hostile situations. Suzanne then lateral transferred to Public Affairs upon completing her aviation contract and finished her esteemed career supporting U.S. Southern Command as a senior Public Affairs advisor. Suzanne has also worked as a technical advisor with Grant Thornton and other companies in business stability operations and international development worldwide. She is a subject matter expert with Wharton Leadership Ventures, part of the McNulty Leadership Program at the Wharton School, University of Pennsylvania. She serves in various capacities for veteran non-profits and is a resiliency advisor for global leaders.

Suzanne recently joined the Kyndryl family as a Federal Partner. Kyndryl is a multi-billion dollar company focusing on mission-critical technology, “the heart and lungs,” which the world depends on daily. She leads the Department of Defense client portfolio.

Suzanne is a graduate of the U.S. Naval Academy with a Bachelor of Science in Political Science and a Spanish minor and has a master’s degree from the University of San Diego in Global Leadership.

She has earned various personal, unit, service, campaign, and international accolades in her military and civilian careers.

Dr. Maan Fares, MD (Chairman, Global Patient Services, The Cleveland Clinic, USA)
Dr. Maan Fares, MD, is a practicing cardiologist in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, and Chairman of Global Patient Services, at the Cleveland Clinic.

Cleveland Clinic is a nonprofit multispecialty academic medical center that integrates clinical and hospital care with research and education. Located in Cleveland, Ohio, it was founded in 1921 by four renowned physicians with a vision of providing outstanding patient care based upon the principles of cooperation, compassion and innovation. Cleveland Clinic has pioneered many medical breakthroughs, including coronary artery bypass surgery and the first face transplant in the United States. U.S.News & World Report consistently names Cleveland Clinic as one of the nation’s best hospitals in its annual “America’s Best Hospitals” survey.

As a global health care organization with an international reputation for excellence in specialty care particularly in cardiovascular diseases. The department of Global Patients Services helps in organizing the care and management of more than 5,000 patients annually. Patients arrive from all corners of the globe with immensely diverse backgrounds seeking various health care needs. Their care demands excellence in management of complex medical illnesses and special cultural awareness to ensure a better experience and superb outcomes.

Dr. Fares is board-certified in cardiovascular disease, nuclear cardiology/cardiovascular imaging (Level II, including SPECT and PET) and echocardiographic imaging (Level II) and has completed Level II training in cardiac CT angiography. He performs nearly 2,000 nuclear stress tests, 2,000 adult echocardiograms, and more than 2,500 stress tests and EKGs each year.

Dr. Fares earned his medical degree from the University of Damascus, School of Medicine, Syria. He completed a residency at Cleveland Clinic, in Cleveland, Ohio, and a fellowship in cardiovascular medicine at New England Medical Center, in Boston, Massachusetts. Dr. Fares spent time on staff at the Massachusetts General Hospital, Boston, as a clinical associate in echocardiography. Prior to his appointment to the Cleveland Clinic medical staff in 2013, Dr. Fares was a member of the Ohio Permanent Medical Group/Kaiser Permanente medical staff and Chief of Cardiology. Additional positions he held with Kaiser Permanente Ohio include Associate Medical Director for Medical Specialties and member of the Board of Directors.

He is a member of the American College of Cardiology, American Society of Echocardiography and the American Society of Nuclear Cardiology and is a founding member of the Syrian American Medical Society.
Mr. Mick Merritt (Chief Operating Officer, Penn Signature Services, Penn Medicine, USA)
Mr. Michael “Mick” Merritt is the Chief Operating Officer of Signature Services at Penn Medicine. In this role, he is responsible for Penn Medicine’s global strategy and programs, patient facilitated services, executive health, and membership programs. He has over twenty years of experience in healthcare and academic medicine as a management consultant and health system leader. His more than twelve-year consulting career has spanned clinical, education and research-related strategic and operational advisory services to academic medical centers and health systems across the U.S. and abroad where he served in leadership roles at Manatt Health and The Chartis Group.

Mr. Merritt's academic health system leadership experience was developed over nine years at New York-Presbyterian (NYP) in collaboration with the Columbia Vagelos College of Physicians & Surgeons and Weill Cornell Medicine, where he last served as Vice President of Global Services. In this role, he led a team of nearly 90 people focused on positioning the organization for referral and revenue growth through direct-to-patient strategies, institutional collaborations, employer initiatives, and global education and training programs.

A recognized industry leader, Mr Merritt served on the Vizient Global Executive Services Council Steering Committee, and he helped establish and was on the founding Advisory Council of the U.S. Cooperative for International Patient Programs. He is also a published author who most recently co-authored a Future of Academic Medicine Series report of the American Association of Medical Colleges entitled “Next-Generation Funds Flow Models: Enhancing Academic Health System Alignment” in October, 2018. He is a graduate of Cornell University with a B.A. in psychology.
Dr. Ann Aerts, MD (Head, The Novartis Foundation, SWITZERLAND)
Dr. Ann Aerts has been Head of the Novartis Foundation since January 2013. During this time, she has led an organization committed to transforming the health of low-income populations. This included working with partners on in-country programs and research to identify the healthcare solutions that work best, supporting partners scaling-up proven solutions, and using the new evidence to inform national and global health policy. Dr. Aerts has led initiatives to improve cardiovascular health in urban populations, co-chaired a Broadband Commission working group that developed recommendations for using digital health to tackle noncommunicable diseases and achieve Universal Health Coverage, and drove a leprosy prevention program that influenced World Health Organization guidelines.

Dr. Aerts’ career has focused on patient centered care, spanning the international humanitarian sector, non-profits and pharma. She was previously Franchise Medical Director for Critical Care at Novartis Pharma in Basel and Therapeutic Area Head of Cardiovascular and Metabolism for Novartis Pharma in Belgium. Prior to joining Novartis, she served as Director of the Lung and Tuberculosis Association in Belgium, Head of the Health Services Department of the International Committee of the Red Cross (ICRC) in Geneva, and Health Coordinator for ICRC in several countries.

In 2014, PharmaVOICE nominated Dr. Aerts as one of the 100 Most Inspiring People in the life science industry. Dr. Aerts has authored numerous publications and is a member of the Broadband Commission, the Governing Council of the UN Technology Bank for Least Developed Countries and the International Advisory Board of the Commonwealth Centre for Digital Health.

Dr. Aerts holds a Degree in Medicine and a Masters in Public Health from the University of Leuven, Belgium, and a Degree in Tropical Medicine from the Institute of Tropical Medicine in Antwerp, Belgium.
Dr. Fredrick Echols, MD (CEO, Cure Violence Global, USA)

Dr. Fredrick L. Echols, the Chief Executive Officer for Cure Violence Global, ranked the No. 9 NGO in the world by NGO Advisor. Dr. Echols is an accomplished physician and public health professional. He has experience in the public and private health sectors. Prior to starting is tenure with Cure Violence Global, he served as the Director of Health and Health Commissioner for the City of St. Louis. In these roles, Dr. Echols oversaw all public health regulations and departmental operations and led the City of St. Louis’ COVID-19 pandemic response.

Prior to serving as the director, Dr. Echols served as director of Communicable Disease, Emergency Preparedness, Vector and Veterinary Programs for the St. Louis County Department of Public Health, where he was responsible for overseeing daily operations, staff development and training, establishment of public-private partnerships, strategic planning, fiscal management of a multi-million-dollar budget and program development and implementation.

Before his position with St. Louis County, Dr. Echols served as Chief of Communicable Diseases for the Illinois Department of Public Health and as a physician in the U.S. Navy, where he managed a staff of medical and ancillary personnel. Additionally, Dr. Echols has served as the principal investigator for local and federally funded public health research initiatives and provides guidance to national and international health workgroups.

Dr. Jasmin Cowin (Professor, TESOL/Bilingual Practicum Coordinator, Touro College, Graduate School of Education, USA)

Dr. Jasmin Cowin is a Fulbright Scholar; Assistant Professor and TESOL/Bilingual Practicum Coordinator at Touro College, Graduate School of Education; Editorial Board member of the Journal of Systemics, Cybernetics, and Informatics for its special issue "Trans-Disciplinary Communication", past chair of the New York State TESOL 2021 conference; sustainability analyst for Computers for Schools Burundi; TESOL expert and Train the Trainer for the Future Horizons Foundation for Translation, Training, and Development in Sanaa, Yemen; retired Chair of the Rotary Club of New York United Nations International Breakfast Meetings; past President and past Rotary Assistant Governor for New York State. Dr. Cowin brings over twenty-five years of experience as an educator, technology specialist and institutional leader. As an Education Policy Fellow at the EPFP™ Institute, Columbia University/Teachers College, she became part of a select group of strategic leaders analyzing trends regarding effective educational policy and leadership with a focus on preparing qualified educators for the complexities of 21st - century classrooms. Her extensive background in education, the Fourth Industrial Revolution, augmented and virtual reality simulation training, Green and Black Swan market shifts, not-for-profit leadership, and commitment to the idea of education as a basic human right provide her with unique skills and vertical networks locally and globally.

Dual Citizenship: US/Germany Native Proficiency: English, German

Sarah Des Rosiers (Director Health Equity, Novartis Foundation, Switzerland)

Ms Sarah Des Rosiers drives multi-sectoral partnerships and initiatives in the space of cardiovascular diseases and digital health for the Novartis Foundation. She is committed to catalyzing and re-imagining innovative solutions to healthcare in low and middle-income countries to tackle some of the most pressing global health inequalities around the world.

She holds an MSc in International Health Policy & Economics from the London School of Economics (LSE) and a MBA from the University of St. Gallen (HSG) in Switzerland. She also holds a certificate from the MIT in Digital Business Strategy: Harnessing Our Digital Future.

With eight years of strategy and management consulting experience in the healthcare sector serving global health and pharma clients, she developed her expertise in the areas of strategy; performance evaluation; grant monitoring; market access and digital health transformations.

Ms Des Rosiers brings an additional three years of hands-on experience working within global heath organizations:

  • with the WHO on topics of access to medicines and pooled procurement;
  • with UNAIDS on areas of technical support planning, systems strengthening initiatives and grant management for the HIV response; and
  • with the Clinton Health Access Initiative (CHAI) providing direct support to the Haitian Ministry of Health post-earthquake 2010 and managing their access to human resources for health program

She currently serves as a member of the Global Shapers Community of the World Economic Forum, with the goal to advance social impact and generate positive change in local communities worldwide.

Ms Des Rosiers is of Haitian-Canadian origin and speaks fluently French, English and Spanish.

Dr. Mark Davis (Chief Operating Officer, Miami Cancer Institute, Part of Baptist Health South Florida, USA)

Dr. Mark A. Davis is an international healthcare expert and physician leader with extensive experience and success in driving business and healthcare network growth, operations, technological innovation, and transnational ventures. Dr. Davis is currently chief operating officer at Miami Cancer Institute, part of Baptist Health South Florida. At Miami Cancer Institute, he is responsible for operational excellence and patient-centered care, playing a key role in developing long-term strategy in the areas of clinical care and developing and acquiring the latest technologies.

Prior to joining Miami Cancer Institute, Dr. Davis came from Brigham and Women’s Hospital in Boston, Massachusetts, where he was vice president of Brigham Health International, leading academic collaborations between Brigham and multiple international parties, and executive director of Business Development and Strategic Initiatives, working on health system and hospital design, education, research and operations both nationally and internationally. He served most recently as senior advisor of Strategic Initiatives and Partnership and as an associate professor of emergency medicine at Harvard Medical School.

Dr. Davis has more than 20 years of experience as a national and global health leader and emergency medicine physician. In collaboration with the Dana-Farber Cancer Institute, he helped establish a multi-billion-dollar advanced cancer hospital in China. He has served as a visiting scientist at NASA Johnson Space Center, an international ambassador to Romania and Israel through the American College of Emergency Physicians, and a member of the World Health Organization’s Essential Trauma Care Program Steering Committee. He has also advanced telehealth platforms internationally and among Native American underserved populations.

Dr. Davis received his medical degree from the University of Pennsylvania School of Medicine, where he was recognized with the Medical Scholar award in 1990. He also has a master’s degree from the University of Pennsylvania Graduate School of Education. He completed an internship and residency in emergency medicine at the University of California, Los Angeles Medical Center. His numerous honors include the Humanitarian Award from the Hippocrates Society, Brigham and Women’s Hospital; the Best Faculty Clinician Award, Harvard Affiliated Emergency Medicine Residency Program, Brigham and Women’s Hospital; and an International Emergency Medicine Fellowship Award from the Ronald Reagan Institute of International Emergency Medicine, George Washington University School of Medicine.

Dr. Davis serves on the editorial boards of many professional journals and has served as reviewer for such publications as the Physician Leadership Journal, Annals of Emergency Medicine, American Journal of Emergency Medicine, European Journal of Emergency Medicine and Biomed Central.

Dr. Michael Salgaller, PhD. (Supervisory Specialist, National Cancer Institute, National Institutes of Health; Board of Directors, Canines-N-Kids (CNK) Foundation; Adjunct Faculty, Foundation for Education in the Sciences, USA)

Dr. Michael Salgaller currently works at the National Cancer Institute, where he leverages over 20 years of business, scientific, and investment experience in various life science sectors to support technology development and commercialization. Previously, he provided technical and strategic expertise to The Conafay Group, a DC-based government affairs firm – leading efforts on non-dilutive funding and alliance development. Prior to that, he was a long-time industry executive who held various positions in biotechnology and professional service firms. In addition, Dr. Salgaller was on the investment team of Toucan Capital, an early-stage venture firm dedicated to healthcare. He began his career as a Senior Staff Scientist at the National Cancer Institute, where he oversaw a lab developing treatments for patients with terminal illnesses.

Dr. Salgaller serves on the Life Sciences Advisory Board of the Maryland Technology Council, and as a liaison to the Maryland-Israel Development Corporation and Maryland Technology Council. He is a reviewer for Washington DC ArchAngels and the Cooperative Angel Alumni Group. He is the author of “Biotechnology Entrepreneurship,” which is used as a reference text for courses at NIH and Catholic University, among others. He is an author of over 100 articles, presentations, and book chapters, and is on the editorial boards of several journals. Dr. Salgaller received his PhD in Pathology from The Ohio State University.

Mr. Johnny Walker (CEO & Chairman, Holo Sail Technologies, Inc., USA)

Mr. John (Johnny) P. Walker II is a graduate of Pace University and the United States Marine Corp where he started his experience in logistics serving in the MT Platoon, Service Company, 6th Comm BN, 4th DV USMC as a 3521 (Diesel Mechanic: 2E). Honorably Discharged at the rank of E-3 in 2002. From there he gained extensive experience in Stevedoring operations from Break Bulk; Liquid transfer; Supervising Union Labor; Trucking; Equipment Control; and Container Marine Operations, in one of the busiest Ports in the western hemisphere. Other areas of Logistical experience include Route Logistics; Warehouse Shipping and Receiving; and, exporting new products globally for product introduction to various Global markets.

Mr. Walker has been featured in two documentaries: The “Science Channel’s” – “Mega Machines – Sea Giants: Season 1: Episode 8 ‘New York Mega Port’” and this year’s winner for “Best Featured Documentary – New York Movie Awards” – “Healing the Heroes of 9-11: The Way Forward”. other appearances include National Television: NewsMax “America Right Now” (two appearances to date). He also has three published articles in various global media outlets.

Dr. Bob T. Li, MD, PHD, MPH (Chief Scientific Officer, MSK DIRECT; CO-DIRECTOR THORACIC LIQUID BIOPSY PROGRAM; PHYSICIAN AMBASSADOR TO CHINA AND ASIA-PACIFIC, MEMORIAL SLOAN KETTERING CANCER CENTER; USA; Associate Professor of Medicine; Weill Cornell Medicine, Cornell University, New York, USA)

Dr. Bob T. Li, MD, PhD, MPH, FRACP, is an Australian medical oncologist and physician-scientist at Memorial Sloan Kettering Cancer Center, New York, and tenure-track associate professor at Weill Cornell Medicine, Cornell University, who specializes in novel drug development for lung cancers and solid tumors. He is Chief Scientific Officer, MSK Direct, responsible for scientific innovation in MSK’s digital outreach strategy. He is also Co-Director of MSK’s multidisciplinary Thoracic Liquid Biopsy Program. Dr. Li is international principal investigator of multiple pivotal clinical trials of precision medicines including “drugging the undruggable” KRAS - and targeting HER2 across multiple cancer types. These efforts have resulted in the FDA approval of the first KRAS inhibitor sotorasib, a milestone in oncology after four decades of research since the discovery of the KRAS oncogene. Dr. Li has received numerous awards for his practice changing research, including the competitive NIH R01 grant and has published over a hundred original articles in prestigious scientific journals including first and senior author manuscripts in the New England Journal of Medicine, Nature, Nature Medicine, Cancer Discovery, and Journal of Clinical Oncology. As MSK’s Physician Ambassador to China and Asia-Pacific, Dr. Li provides administrative leadership to advance MSK’s mission abroad with transparency and impact. In this role, he has helped launch the multi-stakeholder Bloomberg New Economy International Cancer Coalition, and his work on patient-centric international clinical trials as part of a growing global movement is frequently featured on Forbes.com. Through compassionate patient-centric care and by leveraging technology and collaboration, his career is dedicated to bringing the world together to accelerate the cure of cancer in this lifetime.

Mr. H. Delano Roosevelt (President & Chief Executive Officer, U.S.-Saudi Business Council (USSBC), USA)

Mr. H Delano Roosevelt serves as the President and Chief Executive Officer of the U.S.-Saudi Business Council (USSBC). Born in Los Angeles, California, Mr. Delano ("Hal") Roosevelt is the grandson of President Franklin Delano and First Lady Eleanor Roosevelt. He is also the direct descendant of President Theodore Roosevelt. Mr. Roosevelt’s father was James Roosevelt, FDR’s first-born son. He lived on the East Coast when his father served as a Congressman for 6 terms from California’s 26th District, then in Europe when his father was the United Nations Ambassador to Geneva.

Prior to joining the USSBC in December 2019, Mr. Roosevelt served as the Director of New Business Development for the Reza Investment Group, which is wholly owned by the Alireza family, one of the oldest and most respected trading families in Saudi Arabia.

Mr. Roosevelt headed Roosevelt Consulting Inc., an international consulting company focusing on assisting organizations and private investors in structuring cross-border transactions, technology transfers, and direct investments globally with a focus on the Middle East.

He was formerly a member of the Long Beach City Council, where he served in such positions as Chair of the Federal Legislation and Environmental Affairs Committee and Vice-Chair of the Public Safety Committee. Early in his career, he worked at Southern California Edison and the Boeing Sea Launch Program as Director of Governmental Relations.

Delano Roosevelt’s previous involvement also includes:

  • Former Board Member, National Council on U.S.-Arab Relations
  • Former Chairman, Middle East Council of American Chambers of Commerce
  • Executive Board Member, American Mission Hospital, Bahrain
  • First Vice President, Bahrain American Chamber of Commerce
  • Board Member, FDR Warm Springs Institute for Rehabilitation
  • Former Board Member, American Business Association, Eastern Province, Kingdom of Saudi Arabia
Dr. Ali Mokdad, PhD. (Chief Strategy Officer of Population Health;Professor of Health Metrics Science;Director of Middle East Initiatives, Institute for Health Metrics and Evaluation (IHME), The University Of Washington, USA)

Dr. Ali Mokdad, PhD is building the Institute for Health Metrics and Evaluation (IHME) at the University of Washington.  Through new research projects, dissemination and uptake of IHME's methods and results, and consultation with regional leaders in population health, Dr Mokdad has expanded IHME's presence in the region.

Prior to joining IHME, Dr. Mokdad worked at the CDC, starting his career there in 1990. He served in numerous positions with the International Health Program; the Division of Nutrition and Physical Activity; the National Immunization Program; and the National Center for Chronic Diseases Prevention and Promotion, where he was Chief of the Behavioral Surveillance Branch. Dr. Mokdad also managed and directed the Behavioral Risk Factor Surveillance System (BRFSS), the world’s largest standardized telephone survey, which enables the CDC, state health departments, and other health and education agencies to monitor risk behaviors related to the leading causes of morbidity and mortality in the United States.

Dr. Mokdad has published more than 250 articles and numerous reports. He has received several awards, including the Global Health Achievement Award for his work in Banda Aceh after the tsunami; the Department of Health and Human Services Honor Award for his work on flu monitoring; and, the Shepard Award for outstanding scientific contribution to public health for his work on BRFSS. The Behavioral Risk Factor Surveillance System (BRFSS) is the nation’s premier system of health-related telephone surveys that collect state data about U.S. residents regarding their health-related risk behaviors, chronic health conditions, and use of preventive services. Established in 1984 with 15 states, BRFSS now collects data in all 50 states as well as the District of Columbia and three U.S. territories. BRFSS completes more than 400,000 adult interviews each year, making it the largest continuously conducted health survey system in the world.
Dr. Mokdad received his BS in Biostatistics from the American University of Beirut and his PhD in quantitative epidemiology from Emory University.

Mr. Randall Funke (Chief Technology Officer, Holo Sail Technologies, USA)
Mr. Randall Funke is the CTO for Holo Sail Technologies. Mr. Funke is a multitalented and experienced Software Engineer who has over 20 years’ experience working as a Full Stack developer, Data Scientist, and data security specialist with companies like Bloomberg, IBM, General Dynamics, Pennwell Media, Outside Television and many others. His expertise lies in creating secure enterprise level communication and media systems, as well as creating intelligence dashboards from large data sets and data points. As a security developer, he has a deep level of knowledge and experience in cryptography, crown jewel data security, and compliance. Mr. Funke also is a talented guitarist, recording artist and music producer. Randall's outside-the-box approach to development and systems architecture complement the existing and emerging technologies he is fluent in and brings a fresh eye to any project he is involved with.
Dr. Tiffany Traina, MD (Vice Chair, Department of Medicine, Memorial Sloan Kettering Cancer Center, USA)

Dr. Tiffany A. Traina, MD, is Vice Chair of the Department of Medicine and has been a medical oncologist on the Breast Medicine Service since 2006 and has over 23 years of experience in the medical field. She is a board-certified medical oncologist whose clinical practice is dedicated exclusively to the care of patients with all stages of breast cancer. Dr Traina is part of a large, multidisciplinary team of devoted specialists who share her goal of providing exceptional care to patients fighting breast cancer. Through her research activities, she works to develop new therapeutic options for the treatment of breast cancer and to ultimately eradicate this disease.She is also the Section Head of the Triple Negative Breast Cancer Clinical Research Program in which she works to develop new treatment options for this sub-type of breast cancer. Dr. Traina helped lead the restoration of MSK’s outpatient clinical activity during the height of the COVID-19 pandemic. She worked collaboratively with departments across MSK to help determine clinical priorities and optimize aspects of outpatient care. Dr Traina graduated from Joan Sanford I Weill Medical College Of Cornell University medical school in 1999.

Dr. Muhammad Munir Chaudry (President, The Islamic Food and Nutrition Council of America, USA)
Dr. Muhammad Chaudry a career food technologist received his academic education in Pakistan, Lebanon and the United States with a Ph.D. from the University of Illinois at Champaign-Urbana.

For 15 years he worked in the food industry at various technical and management positions, responsible for total quality, quality assurance, human resources and employee training. For the past 30 years, Dr. Chaudry has been managing halal certification programs for the Islamic Food and Nutrition Council of America (IFANCA). Under his administration, halal certification by IFANCA has expanded to over 4000 production sites in 56 countries. Halal certified products include meat and poultry, seafood, food products, food ingredients and chemicals, nutritional products and supplements, cosmetics, personal care products, household products, vaccines, food processing chemicals, sanitation chemicals and packaging materials.

He is a member of the Institute of Food Technologists and expert consultant to the World Organization for Animal Health. He has written several articles and papers in technical journals as well as co-authored a book about Halal Food Production published by CRC PRESS. He was an international delegate for food safety workshops conducted in India, under the sponsorship of the United Nations International Trade Center and the American Spice Trade Association.

Dr. Chaudry is experienced in the management of not-for-profit organizations and industrial corporations in a cross-functional environment.
Dr. Rogelio E. Ribas (Corporate Vice President, Baptist Health International, Part of Baptist Health South Florida, USA)

Dr. Rogelio E. Ribas, M.D., is corporate vice president for Baptist Health International. He is responsible for developing Baptist Health International’s strategic plan, including growth initiatives, resource allocation, long-range planning and leadership development.

In this role, Dr. Ribas leads business development and manages relationships with international insurers, physicians, governments and other potential partners. He also oversees international consulting services, marketing and public relations, PET-CT center in Grand Cayman and a team of 22 in-country managers and representatives across Latin America and the Caribbean.

Dr. Ribas received both his bachelor’s and medical degrees from the Escuela Autónoma de Ciencias Medicas in San Jose, Costa Rica. He has over 25 years of healthcare administration experience, including seven years of HMO experience in utilization review and administration with CAC-Ramsay/United Health Care.

Prior to his current role, he served as assistant vice president of international healthcare partnerships and insurance development for Baptist Health International. He was also previously vice president of operations and client relations for the largest provider of ancillary services in Florida, and vice president of client relations for the largest ancillary provider in Puerto Rico. Dr. Ribas has consulted for private companies internationally to help them present and win numerous government bids, and has been a board member of national and state nonprofit associations in the ancillary field.

Mr. Robert J. Castro (Founder, Bob Castro Strategies, USA)

Mr. Robert ("Bob") Castro, a successful entrepreneur, executive, & Boardroom Advisor, has balanced a 30+ year career between corporate, entrepreneurship, and public service, including 15 years in government and a lifetime in family-owned businesses. Most recently, a Senior Advisor at USAID and the Secretary of State’s Office of Global Partnerships, Mr. Castro spent the prior decade in the private sector focused on new market development and corporate engagement in Diplomacy, Development & Defense, while living in the GCC Region, Egypt, Mexico, Europe/EU, and Washington, DC.

Mr. Castro held a series of appointed roles in the Presidential Transition, supporting confirmation of cabinet members while contributing to new policy initiatives and communication plans for Emergency Preparedness, Innovation, Private Sector Engagement, and Indo-Pacific Strategy, including impact investing and creation of the Development Finance Corporation (DFC). Previously, as Chief of Staff (rank of Principal Deputy Assistant Secretary) for Overseas Buildings Operations (OBO), Mr. Castro oversaw a $1.5 B annual budget, $5.7 B in construction and $14.0 B in assets. He served 10 years on Capitol Hill as professional staff for members of Appropriations, Ways & Means, Transportation & Infrastructure, Science, and Small Business committees and the Office of Technology Assessment.

He was managing VP of a prominent public opinion research firm and Director of Global Security Policy at Lockheed Martin/PAE. He advised executive leadership of the Corporate Council on Africa, US-ASEAN Business Council, and American Chambers of Commerce in Latin America and the MENA region. Widely published and quoted in national press, Bob has appeared on CNN, NPR,C-SPAN, Univision, and Al Jazeera. He produced live content for C3 US-Arab Summits, Rotary International, and a number of global conferences.

Atlanta native and graduate of Georgetown University, Mr. Castro co-chaired the 100th anniversary alumni committee for Villa le Balze in Italy. In 2013, he received DACOR’s Tragen Award for founding "PROPS: Professional Partners & Spouses of the Foreign Service." In 2016, he won AAFSW’s Secretary of State Award for Outstanding Volunteerism Abroad.

Current Advisory Boards:
The World Innovation Network
The Ayadee Foundation & Fellows
The Nourish Movement

Current Advisory Start-ups:
Agromovil (Colombia, Tanzania, Ghana & USA)
Karma Verde Fresh (Mexico & USA)
Various cohorts of Barclays/Unreasonable Impact

Dr. Karen Becker (Area Veterinarian in Charge: DE, MD,VA. WASHINGTON, D.C., USDA, USA)

Dr. Karen Becker currently serves at the USDA as the Area Veterinarian in Charge for Delaware, Maryland, the District of Columbia and Virginia with a focus on preparedness and response to foreign and zoonotic diseases and U.S. animals for public health, food security and trade.

Dr. Karen Becker comes from a distinguished career in public health with focus on preparedness and response to emerging infectious disease threats and preventive medicine. In 2021, she was awarded the One Health Golden Cane Award for her contributions to One Health emphasizing the connections between animal and human health. She earned a Bachelor of Arts from Brown University, a Doctorate of Veterinary Medicine from the University of Illinois’s College of Veterinary Medicine, a Master’s in Public Health from Johns Hopkins University and is board certified by the American College of Veterinary Preventive Medicine.

Before joining the Peace Corps (2018-2021) as Director of the Office of Health Services, she served as the Director of the Applied Epidemiology Staff within USDA’s Food Safety Inspection Service’s Office of Public Health Science. From 2006-2010, D. Becker was on detail by USDA’s Foreign Agricultural Service to USAID’s Africa Bureau to assist with the prevention and control of avian influenza as well as other zoonotic and livestock disease threats impacting public health and agricultural development.

Following September 11, 2001 through 2006, Dr. Becker served as a senior public health advisor to the U.S. Department of Health and Human Service’s Office of Public Health Emergency Preparedness, with a focus on strengthening National and global health security against naturally occurring and intentional public health threats. In 2000, she joined HHS’s Office of Global Heath based in Washington DC to focus on international programs such as zoonotic disease control, Field Epidemiology Training Programs and health systems performance measures.

From 1998-2000, Dr. Becker was a CDC Epidemic Intelligence Service (EIS) Officer based in North Carolina with a focus on infectious disease investigation and response and surveillance during natural disasters such as the major hurricanes experienced during her EIS assignment at North Carolina’s Department of Health. Since 1987 Dr. Becker has maintained her veterinary clinical license and enjoys integrating her clinical and epidemiologic skills to enhance public health and security for all.

Dr. Ahmed Salama, MD (Physician, International Patient Center & Executive Health Program, Brigham and Women’s Hospital, USA)

Dr Salama is a primary care physician at Brigham and Women’s Hospital where he manages the primary care needs of international patients, ensuring quality and cohesive care to patients traveling from abroad and particularly from the Middle East.

Ahmed is a graduate of the Cairo University School of Medicine and has been an internal medicine primary care physician since 2018. He is also certified in obesity medicine and is an AAHIV specialist with extensive experience in international and LGBTQA + medicine.

Prior to starting his residency in 2015, he was part of a medical team affiliated with the International Organization for Migration, a United Nations agency, where he provided direct medical care to in-crisis refugees, vulnerable migrants, and victims of human trafficking. 

Ahmed also earned a degree in Healthcare Management from the American University in Cairo and is knowledgeable in quality assurance with specialization in creation of clinical pathways and hospital protocols.  His experience and training enhanced his ability to relate and provide better care to minority groups and international patients.  Ahmed aims to contribute to the health and well-being of diverse patient populations as well as providing medical education to trainees.

Mr. Steve Lutes (Vice President, Middle East Affairs, U.S. Chamber of Commerce, USA)
Mr. Steve Lutes is Vice President of Middle East Affairs at the U.S. Chamber of Commerce. He is responsible for managing the U.S.-Egypt Business Council, U.S.-Iraq Business Initiative, the U.S.-GCC Business Initiative, and serves as executive director for each. In this capacity, Mr. Lutes is responsible for developing and implementing policies and programs that promote U.S. business opportunities and investment in Egypt, Iraq, Saudi Arabia, the U.A.E., Qatar, Kuwait, Oman and Bahrain. He works closely with Chamber member companies and business and government leaders to deepen and expand commercial relationships.

Mr. Lutes came to the Chamber from the U.S. Department of Commerce’s International Trade Administration (ITA) where he was a senior legislative affairs specialist in the Office of Legislative and Intergovernmental Affairs. He focused on educating members of Congress on the benefits of trade and foreign direct investment and on advancing the Administration’s trade agenda on Capitol Hill, including securing passage of the United States-Dominican Republic-Central America Free Trade Agreement (CAFTA). Mr. Lutes also served as the congressional liaison to the President’s Export Council and the Manufacturing Council for the Department.

Previously, Mr. Lutes worked for the Republican Party in Columbus, Ohio, where he worked in conjunction with the Bush-Cheney reelection effort in Ohio through 2004, successfully directing political and grassroots strategy in central Ohio and helping turnout the largest county vote for former President George W. Bush in Ohio.

Earlier in his career, he worked on Capitol Hill and held a variety of positions, including press secretary, legislative director, and chief of staff.
Mr. John Payne (Chairman & CEO, PURELIFE Health Sciences Group, LLC, USA)
Mr. John Payne is Chairman & CEO of PURELIFE Health Sciences Group and heads a team of scientific researchers focusing on genetics and its relation to diabetes. The Arizona and Florida based research group has spent 23 years researching and identifying causes and solutions to metabolic syndrome health issues based on genetics, DNA based nutritional adaptation, and the interactions between genes that are critical to live long & healthy lives. Significant research has been done in Africa and Australia to identify genetically compatible ingestible sources to support broad spectrum human health, taking into consideration xenohormesis, and how it can affect mitochondrial and telomere health, geography, ethnicity and culture. PURELIFE Health Sciences has bio-engineered scientific formulas and clinical protocols that meet the WHO criteria for being genetically compatible, while reducing inflammation and boosting the immune system resulting in prevention of, and long-term reversal of diabetes. They bridge mankind’s ancient, genetically determined DNA with the biological human needs of today. What we eat and drink must match our inherited DNA to be effective in supporting our overall health and wellness. PURELIFE Health Sciences provides the innovative matched resources for health and healthy weight management.

PROFILE

Researcher • Author • Formulator Product / Ingredient Platform Development More than 35 years of experience in developing ingredient platforms for medical and nutraceutical products domestically and internationally. Devoted to developing natural health products that are genetic based and genetically compatible. Concentrating on ingredient profiles that are based on traditional food resources that address the large and growing need for genetic based nutrition.

HISTORY
  • Research/Development/Technology
  • Nutraceuticals for the prevention and long term reversal of type 2 Diabetes.
  • Platform for fruit & vegetable extracts for health and Diabetes.
  • Plant based high viscosity polysaccharides for menopause symptoms.
  • Nutraceuticals for immune system enhancement.
  • Pure Minerals for bone, teeth, osteoporosis and dental health.
  • Plant based weight loss formulas and body composition improvements that work thru the digestive system.
  • Anti-inflammatory formulas to dampen systemic inflammation.
Mr. R. Chad McClennan (President & CEO, Koios Medical, Inc., USA)

Mr. R. Chad McClennan, president & CEO of Koios Medical, believes ultrasound is a valuable breast imaging tool, particularly in dense-breasted women; however, the imaging results can be impacted by operator variability. Koios Medical (Chicago, IL) recently received its second FDA clearance, this time for using Koios DS (Decision Support) Breast 2.0 at the point of care. The patented software comprises several algorithms that aid clinicians in diagnosing and classifying breast lesions in ultrasound images.

“The accurate interpretation and analysis of breast ultrasound is our initial focus,” says Mr. Chad McClennan. “We are providing decision support on whether something is dangerous or benign. It’s a second opinion and consultation from an expert system to reduce that variability between readers.”

Koios DS Breast 2.0 has been trained on over 400,000 breast ultrasound studies of pathology-proven benign and positive lesions. It can be run directly on the ultrasound system, as is the case with the GE LOGIQ E10, or within a PACS viewer, including systems from FujiFilm Medical, GE Centricity, Sectra, Visage Imaging and others. Findings can be saved and exported to reporting systems to enhance reading efficiency and ease retrieval for follow up. According to Mr. McClennan, the company offers a vendor-agnostic, viewer-based solution that can be downloaded and configured either by Koios or radiology IT administrators—and is also available directly on select scanner hardware. The goal is ultimately to provide a plug-and-play PACS viewer version that could also be available in the exam room, although Mr. McClennan acknowledges that putting it directly on the hardware requires extensive technical development.

The Koios DS solution is offered as a subscription-based model; Mr. McClennan says that’s important for continuously improving and regularly pushing out enhancements, primarily those related to workflow. In 12 months, the company issued four different feature upgrades based on user feedback.

Mr. McClennan ads, “If AI can help in medical imaging, we believe it can help the most in ultrasound, where there is a lower resolution and greater variability across users.

Although the company is focused on image interpretation, Mr. McClennan sees an opportunity for the technology in cancer detection as well as in thyroid and other ultrasound imaging applications.

Mr. Robert M. Kligerman (Chairman, Connecticut Realty Trust, USA)

Mr. Robert M. Kligerman is Chairman of Connecticut Realty Trust. Since purchasing his first urban, multi-family building in 1981, CRT has made it their mission to take ‘sows ears and turn them into silk purses’ by incorporating creative and out-of-the-box ideas and solutions. CRT' current mandate is to stabilize each property which upgrades a neighborhood and beyond. CRT is an integral part of the New Harlem Renaissance and is now applying their skills and disciplines in up-and-coming areas with both Urban and Suburban Renewal. The tangible results of their program has been a ‘win, win, win’ to create clean, attractive, well-kept housing for the tenants that translates into reduced crime and improved quality of life for the neighborhoods, towns and cities, as well as a low risk/high reward portfolio for CRT, their investors and bankers.

CRT’s principals own and manage multi-family and retail assets throughout the northeast quadrant. Mr. Kligerman began his career in Boston as an apartment leasing agent in 1974. From 1977 to 1993 he became a well-known commercial leasing and sales broker in midtown and downtown Manhattan. Specializing then in what were then peripheral and tertiary office markets during which time he closed noteworthy and bell weather transactions. One of which included brokering the sale of the first large commercial condominium in New York City sold to The College Entrance Examination Board in 1984. This won him The Robert E. Lawrence Creative Deal of the Year Award from The Real Estate Board of New York. Over the course of his real estate career he held executive-level positions at Cross & Brown Company, The Galbreath Company and Cushman & Wakefield.

In 1993, he co-founded Prime Realty, a multi-family real estate acquisition and management company specializing in New York City. By 2000, Prime owned and operated 6,500 rental apartment units in 150 buildings. Prime employed 300 people and its institutional partners were Trust Company of the West, Oaktree Financial and Prudential Real Estate Investors.

In 2000, Robert sold his interest in Prime Realty and founded The Kligerman Group. Since then, he has purchased, sold and held over 100 properties. At present, CRT owns and manages approximately 30 real estate assets. CRT's core holdings have historically been New York City multi-family assets in Northern Manhattan, Brooklyn and the Bronx. Mr. Kligerman has since diversified into retail assets in Westchester County, New York and Fairfield County, CT as well as multi-family properties in other strategic areas of the tristate area exclusively with Connecticut Realty Trust LLC (CRT) and his partner, Bard H. Kligerman.

Mr. Bard H. Kligerman (CEO, Connecticut Realty Trust, USA)

Mr. Bard H. Kligerman, Chief Executive Officer and general partner of Connecticut Realty Trust, LLC. Since it’s inception in 2009, he has been responsible for the overall management of the business operations as well as pursuing new investment and financing opportunities. He has overseen the acquisition, management and disposition of over 50 parcels of real estate totaling over $250M.

Mr. Kligerman majored in Finance and Entrepreneurship on his way to earning his Bachelor's degree from Miami University of Ohio. He has worked with his father Mr. Robert Kligerman on numerous real estate ventures. He has also held positions in the real estate and banking industry prior to the formation of Connecticut Realty Trust.

Mr. Ransel N. Potter (Founder, Managing Partner, C3 Summit International, LLC, USA)

Mr. Ransel Potter has been a guest speaker at financial and healthcare events in the Arab region and the United States. His contacts throughout the Arab world and the United States are with the top global financial institutions; high net worth families; and, government representatives, including several Sovereign Wealth Funds and Foreign Ministries; U.S. Department of State; United Nations; U.S. Department of Commerce; U.S. Chamber of Commerce; foreign diplomats; current and past Congressmen and Senators.

The founder and Managing Partner of C3 Summit International, he continues to build a rewarding career spanning three decades, and multiple industries, including many noteworthy achievements. His abilities to lead, strategize, develop business and maintain relationships have all contributed to his success.

In 2011, Mr. Potter founded Copara International which marketed financial research from Value Line to the Arab region. Copara provided technical research versus fundamental data as marketing instruments for quantifying selected public companies for client and institutional trades and investments. He personally negotiated with Value Line the international distribution rights regarding both terms and conditions. In less than 11 months, Mr. Potter established several funds in the Middle East using ValueLine research. One fund was capitalized and managed by the National Bank of Abu Dhabi (the 50th strongest bank in the world). He also was successful in marketing a high yield fund for Thomson Reuters with the National Bank of Abu Dhabi and The National Investor, a top boutique investment banking house located in Dubai. He was also responsible for engaging with the Abu Dhabi Investment Company (Invest AD) an assignment to incorporate a quantitative ranking system, with a $30 million GCC/MENA fund, managed by Invest AD.

In 2012, Mr. Potter founded C3 Summit LLC. Some of the more notable global dignitaries who have key noted past C3 Summits and received the prestigious C3 Lifetime Achievement Award have included: President Bill Clinton; Dr. Henry Kissinger; His Majesty King Hamad Bin Isa Al Khalifa; HRH Prince Faisal Bun Bandar Al Saud; Khalad Ahmed Al Habtoor; General Wesley Clark and General David Petraeus.

The mission of C3 Summit, as noted on its website www.c3summit2018.com is to ensure that both US and Arab businesses grow and prosper by providing unique and valuable commerce opportunities. By creating a global forum for both the US and the Arab world to explore private and public sector growth and employment generation, C3 Summit encourages each region to open new opportunities on the commercial front to enhance "knowledge transfer" and the welfare of freer trade. Since its founding, C3 Summit has partnered with XS conferences in Saudi Arabia to develop the highly successful Saudi-American Healthcare Forum, held annually at the Riyadh Ritz Carlton since 2014. Under the auspices of the Ministry of Health and King Faisal Specialist Hospital and Research Centre, both of whom were engaged by Mr. Potter, the Saudi-American Healthcare Forum, with the leadership of Mr. Potter, has attracted leading healthcare professionals and institutions including, among others: Johns Hopkins, Memorial Sloan Kettering Cancer Center, Huntsman Cancer Foundation, Cleveland Clinic. Sponsors recruited by Mr.Potter have included, to name a few, the Bill & Melinda Gates Foundation, Google, Microsoft, all of whom continue to support the C3 Summits.

Most recently, Mr. Potter, in partnership with XS Conferences &Exhibitions, led a reverse trade mission to the 2018 Jeddah Economic Forum comprised of CEO's from the private and public healthcare and business sectors. And in March of 2019, Mr, Potter conducted the first C3 China-US Healthcare Summit in Beijing. C3 China-US Healthcare Summit, 2019

Prior to founding Copara and C3 Summit, Mr. Potter was in Private Wealth Management with Morgan Stanley and licensed with a Series 7, Series 66 and Series 3. Morgan Stanley recognized the value of Mr. Potter's experience and relationships and, in 2007, they invited him to join the firm. Until December of 2010, Mr. Potter served as a Senior Partner on their Private Wealth Management team responsible for identifying viable business opportunities among high net worth clients, families, hedge funds and foundations. His introductions had been a cornerstone of the team's success producing more than $250 million of net new assets in 36 months.

In 1992, Mr. Potter founded Kinloch Marketing and occupied the role of CEO until 2007. Kinloch designed and brought to market sales lead generation and management systems for the Insurance, Banking and Energy industries. Kinloch's success was a direct result of Mr. Potter's leadership and a network he established with senior executives of Fortune 1000 companies.

In 1990, his previous achievements were recognized by Flair Communications and he was asked to run their NY office. He merged R.N. Potter Associates with Flair's New York office and built that regional office in to the largest of their five domestic offices, leaving in 1992 to establish Kinloch Marketing. He formed R.N. Potter Associates in 1984, a marketing and sales organization, which he headed until 1989. During that time, Mr. Potter personally initiated, negotiated and developed one of the largest independent contracts for advertising billboards with the Penn Central Corporation.

In 1980, Mr. Potter, together with a partner, started On Line Media, an innovative supermarket ad company. Within three years, they took On Line Media public, raising capital and watching the stock soar. Upon selling his shares of On Line Media in 1984, he formed R.N. Potter Associates. Mr. Potter, a graduate of Syracuse University, has six children and, with his wife, lives in Sag Harbor, NY.